Latest News

Published on 16/04/2021, 09:00 | 586hits
sartorius-expands-in-the-uk-by-relocating-to-a-new-facility-for-downstream-processing-equipment
Sartorius Expands in the UK By Relocating to a New Facility for Downstream Processing Equipment
Published on 15/04/2021, 14:00 | 611hits
nouscom-activates-commercial-product-license-for-probiogen-s-proprietary-vaccine-production-cell-line-age1-cr-pix
Nouscom Activates Commercial Product License for ProBioGen’s Proprietary Vaccine Production Cell Line AGE1.CR.pIX®
Published on 14/04/2021, 09:00 | 1062hits
switzerland-bioversys-receives-20-million-in-eu-financing-to-support-development-of-new-antibiotics
Switzerland: BioVersys Receives €20 Million in EU Financing to Support Development of New Antibiotics
Published on 12/04/2021, 11:30 | 1726hits
cellgenix-appoints-daniel-spatz-as-vice-president-sales-marketing-logistics-and-member-of-the-management-team
CellGenix Appoints Daniel Spatz as Vice President Sales, Marketing & Logistics and Member of the Management Team
Published on 12/04/2021, 10:00 | 1049hits
cellbox-solutions-announces-new-headquarters
Cellbox Solutions Announces New Headquarters
Published on 08/04/2021, 12:15 | 1262hits
long-term-toxicology-studies-confirm-very-good-safety-profile-of-mp1032
Long-term Toxicology Studies Confirm Very Good Safety Profile of MP1032
Published on 07/04/2021, 11:00 | 1440hits
delta-4-announces-closing-of-multi-million-series-a-financing-round
Delta 4 Announces Closing of Multi-million Series A Financing Round
Published on 30/03/2021, 13:30 | 6007hits
celonic-and-curevac-announce-agreement-to-manufacture-over-100-million-doses-of-curevac-s-covid-19-vaccine-candidate-cvncov
Celonic and CureVac Announce Agreement to Manufacture over 100 Million Doses of CureVac’s COVID-19 Vaccine Candidate, CVnCoV
Published on 29/03/2021, 10:00 | 2875hits
biomed-x-institute-launches-new-global-call-in-neuroscience-in-collaboration-with-boehringer-ingelheim
BioMed X Institute Launches New Global Call in Neuroscience in Collaboration with Boehringer Ingelheim
Published on 25/03/2021, 16:00 | 2529hits
hyd-substantiates-the-science-of-deuterium-s-role-in-cancer-with-two-new-peer-reviewed-articles
HYD Substantiates the Science of Deuterium's Role in Cancer with Two New Peer-reviewed Articles
Published on 24/03/2021, 14:00 | 2645hits
probiogen-enters-into-agreement-with-nobelpharma-for-manufacturing-process-development-of-their-vaccine-project
ProBioGen Enters into Agreement with Nobelpharma for Manufacturing Process Development of their Vaccine Project
Published on 24/03/2021, 13:00 | 2710hits
scipher-medicine-announces-82-million-financing
Scipher Medicine Announces $82 Million Financing
Published on 22/03/2021, 16:00 | 2901hits
celonic-group-and-university-college-london-ucl-announce-partnership-to-produce-protein-therapeutics-using-celonic-s-chovolution-platform
Celonic Group and University College London (UCL) Announce Partnership to Produce Protein Therapeutics using Celonic’s CHOvolution® Platform
Published on 17/03/2021, 14:00 | 3745hits
probiogen-licenses-glymaxx-technology-to-sanofi
ProBioGen Licenses GlymaxX® Technology to Sanofi
Published on 16/03/2021, 13:30 | 3201hits
more-than-half-of-physicians-have-seen-an-increase-in-patients-who-are-unhoused-or-in-poverty-over-the-past-year
More Than Half of Physicians Have Seen an Increase in Patients Who Are Unhoused or in Poverty Over the Past Year
Published on 16/03/2021, 10:00 | 3299hits
navigo-proteins-and-eleva-announce-successful-development-of-an-affinity-chromatography-resin-customized-for-the-efficient-purification-of-human-complement-factor-h
Navigo Proteins and Eleva Announce Successful Development of an Affinity Chromatography Resin Customized for the Efficient Purification of Human Complement-Factor H
Published on 08/03/2021, 15:15 | 4756hits
vetter-establishes-office-in-china-to-better-serve-the-needs-of-its-growing-customer-base-worldwide
Vetter Establishes Office in China to Better Serve the Needs of Its Growing Customer Base Worldwide
Published on 25/02/2021, 16:00 | 9607hits
celonic-to-boost-its-cell-gene-therapy-production-with-facility-in-the-upcoming-life-science-park-rheintal-in-stein-switzerland
Celonic to Boost its Cell & Gene Therapy Production with Facility in the Upcoming Life Science Park Rheintal in Stein, Switzerland
Published on 24/02/2021, 13:30 | 5123hits
toxys-strengthens-executive-team-with-appointment-of-a-cso
Toxys Strengthens Executive Team with Appointment of a CSO
Published on 22/02/2021, 13:00 | 6468hits
novalgen-enters-strategic-partnership-with-halix-b-v-to-manufacture-clinical-trial-materials
NovalGen Enters Strategic Partnership with HALIX B.V. to Manufacture Clinical Trial Materials
Published on 22/02/2021, 09:00 | 5677hits
maxivax-and-minaris-regenerative-medicine-enter-into-a-manufacturing-partnership-for-mvx-onco-2-cancer-immunotherapy
MaxiVAX and Minaris Regenerative Medicine Enter into a Manufacturing Partnership for MVX-ONCO-2 Cancer Immunotherapy
Published on 18/02/2021, 16:00 | 5446hits
vetter-continues-its-successful-performance-at-the-2021-cmo-leadership-awards
Vetter Continues Its Successful Performance at the 2021 CMO Leadership Awards
Published on 17/02/2021, 09:00 | 6437hits
almirall-and-mc2-therapeutics-enter-a-license-collaboration-and-commercialization-agreement-for-european-rights-to-wynzora-cream-for-treatment-of-plaque-psoriasis
Almirall and MC2 Therapeutics Enter a License, Collaboration and Commercialization Agreement for European Rights to Wynzora® Cream for Treatment of Plaque Psoriasis
Published on 10/02/2021, 12:00 | 7283hits
thrombolytic-science-reinforces-its-ip-portfolio-with-patents-in-europe-the-commonwealth-of-independent-states-and-japan
Thrombolytic Science Reinforces Its IP Portfolio with Patents in Europe, the Commonwealth of Independent States and Japan
Published on 10/02/2021, 09:00 | 6661hits
european-commission-grants-vico-therapeutics-orphan-drug-designation-for-vo659-an-investigational-therapy-for-spinocerebellar-ataxia
European Commission Grants Vico Therapeutics Orphan Drug Designation for VO659, an Investigational Therapy for Spinocerebellar Ataxia
Published on 03/02/2021, 09:30 | 7254hits
bd-announces-assay-for-identification-of-covid-19-patients-at-increased-relative-risks-of-intubation-with-mechanical-ventilation-mortality-at-hospital-admission-now-available-in-europe
BD Announces Assay for Identification of COVID-19 Patients at Increased Relative Risks of Intubation with Mechanical Ventilation, Mortality at Hospital Admission Now Available in Europe
Published on 02/02/2021, 09:30 | 7627hits
scenic-biotech-appoints-dr-philippe-dro-as-independent-chairman
Scenic Biotech Appoints Dr. Philippe Dro as Independent Chairman
Published on 02/02/2021, 09:00 | 6996hits
harbour-biomed-and-probiogen-agree-on-a-glymaxx-license-to-fast-track-cell-line-development-projects
Harbour BioMed and ProBioGen Agree on a GlymaxX® License to Fast-Track Cell Line Development Projects
Published on 01/02/2021, 18:00 | 7652hits
recipharm-and-medspray-launch-resyca-joint-venture-to-exploit-novel-softmist-technology-for-pharmaceutical-applications
Recipharm and Medspray Launch Resyca Joint Venture to Exploit Novel Softmist Technology for Pharmaceutical Applications
Published on 28/01/2021, 13:30 | 7166hits
toxys-leiden-university-and-leiden-university-medical-center-announce-licensing-of-toxprofiler-technology-for-animal-free-chemical-safety-testing
Toxys, Leiden University and Leiden University Medical Center Announce Licensing of ToxProfiler Technology for Animal-Free Chemical Safety Testing
Published on 26/01/2021, 14:00 | 7206hits
86-of-doctors-believe-mental-health-issues-depression-will-be-the-biggest-non-covid-19-issue-as-a-result-of-the-pandemic
86% of Doctors Believe Mental Health Issues, Depression Will be the Biggest non-COVID-19 Issue as a Result of the Pandemic
Published on 26/01/2021, 09:00 | 6668hits
biomed-x-institute-starts-new-research-project-in-drug-delivery-in-collaboration-with-janssen
BioMed X Institute Starts New Research Project in Drug Delivery in Collaboration with Janssen
Published on 21/01/2021, 16:00 | 6072hits
probiogen-licenses-glymaxx-technology-to-abbvie
ProBioGen Licenses GlymaxX® Technology to AbbVie
Published on 20/01/2021, 14:00 | 9359hits
impel-neuropharma-announces-u-s-food-drug-administration-acceptance-of-new-drug-application-for-inp104-for-the-acute-treatment-of-migraine
Impel NeuroPharma Announces U.S. Food & Drug Administration Acceptance of New Drug Application for INP104 for the Acute Treatment of Migraine
Published on 18/01/2021, 09:30 | 6738hits
implandata-s-eyemate-system-protects-glaucoma-patients-even-during-lockdown
Implandata’s EYEMATE System Protects Glaucoma Patients – Even During Lockdown
Published on 15/01/2021, 10:30 | 5947hits
in-person-and-virtual-pharma-partnering-combined
In-Person and Virtual Pharma Partnering Combined
Published on 11/01/2021, 15:00 | 6218hits
byondis-announces-upcoming-presentation-at-j-p-morgan-healthcare-conference
Byondis Announces Upcoming Presentation at J.P. Morgan Healthcare Conference
Published on 21/12/2020, 14:30 | 9912hits
biomedion-ag-announces-the-acquisition-of-the-compliance-division-of-arivis-ag
BioMedion AG Announces the Acquisition of the Compliance Division of arivis AG
Published on 17/12/2020, 09:00 | 9994hits
immune-regulation-appoints-new-chairman-and-builds-out-senior-management-team-with-standout-industry-professionals-in-the-us
Immune Regulation Appoints New Chairman and Builds Out Senior Management Team with Standout Industry Professionals in the US
Published on 16/12/2020, 14:00 | 9088hits
relaxera-and-cbl-patras-announce-exclusive-agreement-on-manufacturing-and-sales-of-synthetic-human-relaxin-2
Relaxera and CBL Patras Announce Exclusive Agreement on Manufacturing and Sales of Synthetic Human Relaxin-2
Published on 14/12/2020, 14:00 | 9318hits
pepscope-secures-investment-to-radically-improve-development-and-application-of-kinase-inhibitor-therapies
Pepscope Secures Investment to Radically Improve Development and Application of Kinase Inhibitor Therapies
Published on 11/12/2020, 14:00 | 9082hits
puma-biotechnology-presents-final-overall-survival-analysis-from-the-phase-iii-extenet-trial-at-the-2020-sabcs
Puma Biotechnology Presents Final Overall Survival Analysis from the Phase III ExteNET Trial at the 2020 SABCS
Published on 09/12/2020, 09:00 | 8966hits
new-clinical-trial-data-demonstrates-bd-libertas-wearable-injector-as-a-drug-delivery-system
New Clinical Trial Data Demonstrates BD Libertas™ Wearable Injector as a Drug Delivery System
Published on 08/12/2020, 15:00 | 8998hits
seranovo-appoints-michiel-van-speybroeck-as-chief-development-officer-as-lead-programs-progress-through-clinical-studies
SeraNovo Appoints Michiel Van Speybroeck as Chief Development Officer as Lead Programs Progress Through Clinical Studies
Published on 08/12/2020, 13:30 | 9871hits
halix-signs-agreement-with-astrazeneca-for-commercial-manufacture-of-covid-19-vaccine
HALIX Signs Agreement with AstraZeneca for Commercial Manufacture of COVID-19 Vaccine
Published on 08/12/2020, 10:00 | 8893hits
biomed-x-institute-completes-first-research-project-in-neuroscience-with-boehringer-ingelheim
BioMed X Institute Completes First Research Project in Neuroscience with Boehringer Ingelheim
Published on 08/12/2020, 09:00 | 7105hits
osteolabs-gmbh-successfully-closes-second-financing-round-of-nearly-1-6-million-eur
osteolabs GmbH Successfully Closes Second Financing Round of Nearly 1.6 Million EUR
Published on 08/12/2020, 09:00 | 11657hits
retinai-announces-collaboration-with-novartis-to-provide-artificial-intelligence-solutions-in-ophthalmology
RetinAI Announces Collaboration with Novartis to Provide Artificial Intelligence Solutions in Ophthalmology
Published on 03/12/2020, 15:45 | 7491hits
vetter-continues-to-implement-its-long-term-sustainability-strategy
Vetter Continues to Implement its Long-Term Sustainability Strategy
Published on 30/11/2020, 09:00 | 7905hits
fire-monkey-v8-hmw-dna-extraction-delivers-30gb-yield-from-sequencing-on-the-ont-minion
Fire Monkey v8 HMW DNA Extraction Delivers 30Gb+ Yield from Sequencing on the ONT MinION
Published on 23/11/2020, 14:00 | 9376hits
mustang-bio-and-minaris-regenerative-medicine-sign-technology-transfer-and-gmp-manufacturing-agreement-for-mb-107-lentiviral-gene-therapy-for-x-linked-severe-combined-immunodeficiency
Mustang Bio and Minaris Regenerative Medicine Sign Technology Transfer and GMP Manufacturing Agreement for MB-107 Lentiviral Gene Therapy for X-Linked Severe Combined Immunodeficiency
Published on 20/11/2020, 15:05 | 11109hits
marinomed-biotech-plans-clinical-trial-with-carragelose-nasal-spray-to-investigate-prevention-of-covid-19-infection-in-frontline-healthcare-staff
Marinomed Biotech Plans Clinical Trial with Carragelose Nasal Spray to Investigate Prevention of COVID-19 Infection in Frontline Healthcare Staff
Published on 19/11/2020, 10:30 | 8130hits
covid-19-treatment-for-the-most-severely-affected-patients-after-promising-results-in-named-patient-use-clinical-trial-with-fx06-starts-in-france
COVID-19: Treatment for the Most Severely Affected Patients - After Promising Results in Named Patient Use - Clinical Trial with FX06 Starts in France
Published on 18/11/2020, 14:00 | 7926hits
asahi-kasei-pharma-contracts-probiogen-for-the-advancement-of-their-biologics-pipeline
Asahi Kasei Pharma Contracts ProBioGen for the Advancement of their Biologics Pipeline
Published on 18/11/2020, 09:00 | 8209hits
bioversys-announces-first-subjects-dosed-in-phase-1-clinical-trial-of-bv100
BioVersys Announces First Subjects Dosed in Phase 1 Clinical Trial of BV100
Published on 16/11/2020, 10:00 | 8342hits
calypso-biotech-announces-successful-dosing-of-first-phase-1-cohort-with-anti-interleukin-15-il-15-monoclonal-antibody-caly-002-for-the-treatment-of-autoimmune-diseases
Calypso Biotech Announces Successful Dosing of First Phase 1 Cohort with Anti-Interleukin-15 (IL-15) Monoclonal Antibody CALY-002 for the Treatment of Autoimmune Diseases
Published on 16/11/2020, 09:00 | 7896hits
lead-pharma-enters-into-a-research-collaboration-and-license-agreement-with-roche-to-develop-oral-small-molecules-for-immune-mediated-diseases
Lead Pharma Enters into a Research Collaboration and License Agreement with Roche to Develop Oral Small Molecules for Immune Mediated Diseases
Published on 12/11/2020, 09:00 | 8384hits
byondis-to-present-at-the-jefferies-2020-virtual-healthcare-conference
Byondis to Present at the Jefferies 2020 Virtual Healthcare Conference
Published on 11/11/2020, 15:15 | 8525hits
sotio-presents-interim-data-from-its-phase-1-1b-study-of-so-c101-in-patients-with-advanced-solid-tumors-at-sitc-2020
SOTIO Presents Interim Data from its Phase 1/1b Study of SO-C101 in Patients with Advanced Solid Tumors at SITC 2020
Published on 09/11/2020, 10:00 | 9334hits
biomed-x-institute-announces-expansion-of-their-strategic-collaboration-with-janssen-in-immunology-research
BioMed X Institute Announces Expansion of their Strategic Collaboration with Janssen in Immunology Research
Published on 05/11/2020, 12:00 | 10176hits
proteonic-announces-licensing-of-its-2g-unic-technology-platform-for-production-of-biologics-to-gilead-sciences
ProteoNic Announces Licensing of its 2G UNic™ Technology Platform for Production of Biologics to Gilead Sciences
Published on 04/11/2020, 15:00 | 9660hits
sotio-to-present-new-data-on-the-il-15-superagonist-so-c101-at-the-society-for-immunotherapy-of-cancer-sitc-35th-annual-meeting
SOTIO to Present New Data on the IL-15 Superagonist SO-C101 at the Society for Immunotherapy of Cancer (SITC) 35th Annual Meeting
Published on 04/11/2020, 09:00 | 9895hits
saillant-therapeutics-reports-proof-of-concept-of-its-treatment-in-heart-failure-showing-functional-reversal-and-myocardial-rejuvenation
Saillant Therapeutics Reports Proof of Concept of its Treatment in Heart Failure Showing Functional Reversal and Myocardial Rejuvenation
Published on 02/11/2020, 09:30 | 13245hits
hearing-loss-company-acousia-therapeutics-strengthening-its-r-d-management-team
Hearing Loss Company Acousia Therapeutics Strengthening its R&D Management Team
Published on 02/11/2020, 08:20 | 10099hits
minaris-regenerative-medicine-to-significantly-expand-manufacturing-capacity-for-cell-and-gene-therapies-in-germany-and-japan
Minaris Regenerative Medicine to Significantly Expand Manufacturing Capacity for Cell and Gene Therapies in Germany and Japan
Published on 30/10/2020, 10:15 | 10484hits
amarna-therapeutics-appoints-kite-pharma-veteran-dr-markwin-velders-to-its-supervisory-board
Amarna Therapeutics Appoints Kite Pharma Veteran Dr. Markwin Velders to its Supervisory Board
Published on 27/10/2020, 14:00 | 10358hits
probiogen-s-productivity-increasing-pathway-modulator-technology-used-by-immunos-therapeutics
ProBioGen's Productivity Increasing Pathway Modulator Technology Used by ImmunOs Therapeutics
Published on 22/10/2020, 14:00 | 11110hits
heidelberg-pharma-contracts-probiogen-for-cell-line-development-and-manufacturing-services
Heidelberg Pharma Contracts ProBioGen for Cell Line Development and Manufacturing Services
Published on 21/10/2020, 15:45 | 10171hits
vetter-continues-its-long-term-investment-strategy-to-sustain-future-growth
Vetter Continues its Long-Term Investment Strategy to Sustain Future Growth
Published on 21/10/2020, 10:00 | 9981hits
raucon-announces-changes-to-europlx-and-asiaplx-pharma-partnering-events
RauCon Announces Changes to euroPLX and asiaPLX Pharma Partnering Events
Published on 20/10/2020, 10:00 | 10857hits
proteonic-announces-licensing-of-technology-for-production-of-biologics-to-immunomedics
ProteoNic Announces Licensing of Technology for Production of Biologics to Immunomedics
Published on 16/10/2020, 09:00 | 11575hits
bd-announces-assay-for-immune-assessment-of-covid-19-patients-now-available-in-europe
BD Announces Assay for Immune Assessment of COVID-19 Patients Now Available in Europe
Published on 13/10/2020, 10:30 | 11358hits
prestige-biopharma-receives-positive-ema-opinion-on-orphan-designation-for-pbp1510-for-treatment-of-pancreatic-cancer
Prestige Biopharma Receives Positive EMA Opinion on Orphan Designation for PBP1510 for Treatment of Pancreatic Cancer
Published on 13/10/2020, 10:00 | 10915hits
f4-pharma-announces-formation-of-scientific-advisory-board
F4 Pharma Announces Formation of Scientific Advisory Board
Published on 08/10/2020, 15:00 | 11610hits
impel-neuropharma-presents-data-from-pivotal-phase-3-registration-study-of-inp104-for-the-treatment-of-acute-migraine-at-2020-migraine-trust-virtual-symposium
Impel Neuropharma Presents Data from Pivotal Phase 3 Registration Study of INP104 for the Treatment of Acute Migraine at 2020 Migraine Trust Virtual Symposium
Published on 08/10/2020, 10:30 | 11373hits
cellgenix-completes-facility-expansion-to-stay-ahead-of-the-increasing-demand-for-gmp-raw-materials
CellGenix Completes Facility Expansion to Stay Ahead of the Increasing Demand for GMP Raw Materials
Published on 01/10/2020, 12:30 | 19497hits
navigo-proteins-and-repligen-announce-achievement-of-a-key-milestone-in-development-of-an-affinity-resin-for-the-purification-of-covid-19-vaccines
Navigo Proteins and Repligen Announce Achievement of a Key Milestone in Development of an Affinity Resin for the Purification of COVID-19 Vaccines
Published on 01/10/2020, 10:00 | 11744hits
admedicum-business-for-patients-announce-expansion-into-the-netherlands-and-strengthening-of-its-leadership-team
admedicum Business for Patients Announce Expansion into the Netherlands and Strengthening of its Leadership Team
Published on 01/10/2020, 09:00 | 11750hits
dutch-vico-therapeutics-strengthens-leadership-team-with-the-appointment-of-rupert-sandbrink-as-chief-medical-officer-and-anders-hinsby-as-independent-director
Dutch Vico Therapeutics Strengthens Leadership Team with the Appointment of Rupert Sandbrink as Chief Medical Officer and Anders Hinsby as Independent Director
Published on 30/09/2020, 09:05 | 11790hits
bd-announces-ce-mark-of-portable-rapid-point-of-care-antigen-test-to-detect-sars-cov-2-in-15-minutes
BD Announces CE Mark of Portable, Rapid Point-of-Care Antigen Test to Detect SARS-CoV-2 in 15 Minutes
Published on 29/09/2020, 09:00 | 11493hits
cristal-therapeutics-announces-a-publication-in-chemical-science-on-clicr-technology-platform-comprising-a-new-class-of-superior-copper-free-click-reagents-for-conjugation-of-small-molecules-biologics-nanoparticles-and-other-moieties
Cristal Therapeutics Announces a Publication In ‘Chemical Science’ On CliCr® Technology Platform, Comprising a New Class of Superior Copper Free Click Reagents for Conjugation of Small Molecules, Biologics, Nanoparticles and Other Moieties
Published on 28/09/2020, 08:00 | 11798hits
fundacion-medina-dndi-and-institut-pasteur-korea-announce-new-funding-from-la-caixa-health-research-for-research-partnership-to-discover-new-natural-products-against-leishmaniasis-and-chagas-disease
Fundación MEDINA, DNDi and Institut Pasteur Korea Announce New Funding from “La Caixa” Health Research for Research Partnership to Discover New Natural Products Against Leishmaniasis and Chagas Disease
Published on 25/09/2020, 12:00 | 35430hits
ai-for-biopharmaceutical-production-sartorius-a-new-shareholder-in-dfki-the-german-research-center-for-artificial-intelligence
AI for Biopharmaceutical Production – Sartorius a New Shareholder in DFKI, the German Research Center for Artificial Intelligence
Published on 25/09/2020, 12:00 | 11454hits
dutch-amarna-therapeutics-enters-research-collaboration-with-spanish-fps-examining-the-efficacy-of-its-sv40-based-svec-gene-delivery-vector-platform-technology-in-diabetes-mellitus-type-1-and-multiple-sclerosis
Dutch Amarna Therapeutics Enters Research Collaboration with Spanish FPS, Examining the Efficacy of its SV40-Based SVec™ Gene Delivery Vector Platform Technology in Diabetes Mellitus Type 1 and Multiple Sclerosis
Published on 23/09/2020, 08:00 | 14459hits
hitachi-chemical-s-global-regenerative-medicine-business-renamed-minaris-regenerative-medicine
Hitachi Chemical’s Global Regenerative Medicine Business Renamed Minaris Regenerative Medicine
Published on 23/09/2020, 07:00 | 11484hits
pureos-bioventures-closes-first-fund-with-usd-170-million
Pureos Bioventures Closes First Fund with USD 170 Million
Published on 21/09/2020, 09:00 | 11764hits
immune-regulation-limited-raises-40-6-million-53-4-million-series-b-equity-financing
Immune Regulation Limited Raises £40.6 Million / $53.4 Million Series B Equity Financing
Published on 15/09/2020, 15:15 | 11442hits
live-event-recent-austrian-corona-measures-validate-new-europlx-concept
Live Event: Recent Austrian Corona Measures Validate New euroPLX Concept
Published on 15/09/2020, 09:00 | 11728hits
first-patients-treated-in-first-in-human-trial-for-actiseal-polyganics-innovative-liver-and-pancreas-sealant-patch
First Patients Treated in First-in-Human Trial for ACTISEAL® - Polyganics' Innovative Liver and Pancreas Sealant Patch
Published on 08/09/2020, 09:00 | 12263hits
immune-regulation-ltd-receives-notice-of-allowance-for-new-u-s-patent-for-its-novel-protein-with-anti-inflammatory-properties
Immune Regulation Ltd Receives Notice of Allowance for New U.S. Patent for its Novel Protein with Anti-Inflammatory Properties
Published on 07/09/2020, 14:00 | 12825hits
icanomab-gmbh-founded-with-private-funding-to-develop-precision-canonical-monoclonal-antibodies-in-oncology-immune-modulation-acute-inflammation-and-most-urgently-for-covid-19
IcanoMAB GmbH Founded with Private Funding to Develop Precision Canonical Monoclonal Antibodies in Oncology, Immune-Modulation, Acute Inflammation and Most Urgently for Covid-19
Published on 07/09/2020, 10:30 | 11283hits
new-concept-allows-physical-partnering-event
New Concept Allows Physical Partnering Event
Published on 03/09/2020, 14:15 | 12997hits
ime-medical-electrospinning-secured-3-million-in-new-financing-from-dutch-vcs-borski-fund-lumana-invest-tiin-capital-and-from-rabobank-to-further-expand-its-medispin-xl-production-platform
IME Medical Electrospinning Secured € 3 Million in New Financing From Dutch VCs Borski Fund, Lumana Invest, TIIN Capital and From Rabobank to Further Expand its Medispin XL Production Platform
Published on 03/09/2020, 09:30 | 12440hits
dutch-amarna-therapeutics-announces-the-appointment-of-steen-klysner-as-chief-executive-officer
Dutch Amarna Therapeutics Announces the Appointment of Steen Klysner as Chief Executive Officer
Published on 01/09/2020, 09:00 | 12500hits
bioversys-announces-chf-19-million-financing-to-advance-novel-amr-candidates-into-clinical-development
BioVersys Announces CHF 19 Million Financing to Advance Novel AMR Candidates into Clinical Development
Published on 31/08/2020, 13:45 | 12524hits
sotio-acquires-rights-to-boxr-car-t-platform-and-products-from-unum-therapeutics
SOTIO Acquires Rights to BOXR CAR-T Platform and Products from Unum Therapeutics
Published on 26/08/2020, 09:00 | 12559hits
3d-cell-culture-systems-in-cancer-organoids-reveal-drug-efficacy-that-is-undetectable-in-traditional-2d-monolayer-systems
3D Cell Culture Systems in Cancer Organoids Reveal Drug Efficacy that is Undetectable in Traditional 2D Monolayer Systems
Published on 25/08/2020, 09:00 | 12493hits
byondis-initiates-phase-i-study-of-adc-vic-trastuzumab-duocarmazine-niraparib-in-her2-expressing-solid-tumors
Byondis Initiates Phase I Study of ADC [Vic-]Trastuzumab Duocarmazine + Niraparib in HER2-Expressing Solid Tumors
Published on 24/08/2020, 16:15 | 12725hits
new-nasal-gel-evaluated-for-its-protective-action-against-human-rhinovirus-16-hrv-a16-infection-in-nasal-epithelial-cells
New Nasal Gel Evaluated for its Protective Action Against Human Rhinovirus 16 (HRV-A16) Infection in Nasal Epithelial Cells
Published on 24/08/2020, 15:15 | 12388hits
mc2-therapeutics-announces-collaboration-agreement-with-epi-health-on-commercialization-of-newly-approved-psoriasis-drug-wynzora-cream-in-the-us
MC2 Therapeutics Announces Collaboration Agreement with EPI Health on Commercialization of Newly Approved Psoriasis Drug, WYNZORA® Cream, in the US
Published on 20/08/2020, 09:00 | 12335hits
hercules-ahr-inhibitor-hp163-blocks-viral-replication-in-zika-infection-and-potentially-in-covid-19
Hercules' AhR Inhibitor HP163 Blocks Viral Replication in Zika Infection and Potentially in Covid-19
Published on 19/08/2020, 09:00 | 12491hits
byondis-announces-appointment-of-chief-financial-officer
Byondis Announces Appointment of Chief Financial Officer
Published on 11/08/2020, 09:00 | 12893hits
byondis-initiates-phase-i-study-of-antibody-drug-conjugate-syd1875
Byondis Initiates Phase I Study of Antibody-Drug Conjugate SYD1875
Published on 11/08/2020, 07:45 | 12721hits
dutch-saillant-therapeutics-to-develop-generic-virus-inhibiting-therapy-based-on-activation-of-a-cellular-master-regulator-ending-virus-replication
Dutch Saillant Therapeutics to Develop Generic Virus Inhibiting Therapy Based on Activation of a Cellular Master Regulator, Ending Virus Replication
Published on 29/07/2020, 17:20 | 13123hits
a-strong-signal-in-turbulent-times-vetter-achieves-carbon-dioxide-neutral-levels
A Strong Signal in Turbulent Times: Vetter Achieves Carbon Dioxide-Neutral Levels
Published on 29/07/2020, 14:00 | 13572hits
intravacc-and-celonic-to-develop-and-produce-a-novel-covid-19-vaccine
Intravacc and Celonic to Develop and Produce a Novel COVID-19 Vaccine
Published on 27/07/2020, 10:00 | 15640hits
digital-health-clinical-study-published-in-ophthalmology-demonstrates-implandata-s-eyemate-system-benefits-glaucoma-patients
Digital Health: Clinical Study Published in “Ophthalmology” Demonstrates Implandata’s EYEMATE System Benefits Glaucoma Patients
Published on 22/07/2020, 10:00 | 13555hits
mc2-therapeutics-announces-u-s-food-and-drug-administration-approval-of-wynzora-cream-calcipotriene-and-betamethasone-dipropionate-w-w-0-005-0-064-for-adults-with-plaque-psoriasis
MC2 Therapeutics Announces U.S. Food and Drug Administration Approval of Wynzora® Cream (calcipotriene and betamethasone dipropionate w/w 0.005%/0.064%) for Adults with Plaque Psoriasis
Published on 15/07/2020, 09:00 | 15027hits
byondis-initiates-phase-ii-study-of-antibody-drug-conjugate-vic-trastuzumab-duocarmazine-in-advanced-endometrial-cancer
Byondis Initiates Phase II Study of Antibody-Drug Conjugate [Vic-]Trastuzumab Duocarmazine in Advanced Endometrial Cancer
Published on 14/07/2020, 15:00 | 13431hits
sotio-announces-first-patient-dosed-in-part-b-of-phase-1-1b-study-with-so-c101-in-combination-with-pembrolizumab-in-patients-with-solid-tumors
SOTIO Announces First Patient Dosed in Part B of Phase 1/1b Study with SO-C101 in Combination with Pembrolizumab in Patients with Solid Tumors
Published on 14/07/2020, 14:00 | 13591hits
toxys-appoints-susan-swarte-as-new-non-executive-board-member
Toxys Appoints Susan Swarte as New Non-Executive Board Member
Published on 08/07/2020, 16:30 | 14733hits
vetter-further-expands-its-development-service-with-new-site-in-austria
Vetter Further Expands its Development Service with New Site in Austria
Published on 06/07/2020, 11:15 | 14920hits
rentschler-biopharma-and-vetter-team-up-with-joint-goal-to-simplify-processes-and-optimize-time-to-market
Rentschler Biopharma and Vetter Team Up with Joint Goal to Simplify Processes and Optimize Time-To-Market
Published on 06/07/2020, 09:00 | 14619hits
immune-regulation-ltd-partners-with-dynport-vaccine-company-to-advance-its-drug-product-for-covid-19-into-clinical-trials
Immune Regulation Ltd Partners with DynPort Vaccine Company to Advance its Drug Product for COVID-19 into Clinical Trials
Published on 02/07/2020, 13:00 | 13675hits
osteolabs-gmbh-provides-further-validation-for-use-of-osteotest-in-osteoporosis-and-early-stage-kidney-malfunction
osteolabs GmbH Provides Further Validation for Use of OsteoTest in Osteoporosis and Early-Stage Kidney Malfunction
Published on 01/07/2020, 14:00 | 13642hits
sotio-appoints-richard-sachse-as-chief-medical-officer
SOTIO Appoints Richard Sachse as Chief Medical Officer
Published on 30/06/2020, 09:00 | 15817hits
us-fda-grants-orphan-drug-designation-odd-for-prestige-biopharma-s-pbp1510-anti-pauf-monoclonal-antibody-for-the-treatment-of-pancreatic-cancer
US FDA Grants Orphan Drug Designation (ODD) for Prestige BioPharma’s PBP1510 Anti-PAUF Monoclonal Antibody for the Treatment of Pancreatic Cancer
Published on 25/06/2020, 09:00 | 15904hits
polares-medical-closes-a-40m-financing-to-complete-pilot-clinical-studies
Polares Medical Closes a $40M Financing to Complete Pilot Clinical Studies
Published on 24/06/2020, 09:00 | 13771hits
biogeneration-ventures-closes-bgv-iv-fund-at-105-million
BioGeneration Ventures Closes BGV IV Fund at €105 Million
Published on 23/06/2020, 09:00 | 14419hits
first-participant-dosed-in-phase-1-clinical-study-with-vtp-300-immunotherapeutic-to-treat-chronically-infected-hepatitis-b-patients
First Participant Dosed in Phase 1 Clinical Study with VTP-300 Immunotherapeutic to Treat Chronically Infected Hepatitis B Patients
Published on 22/06/2020, 15:00 | 13150hits
sotio-presents-new-data-showing-strong-anti-tumor-effect-of-il-15-superagonist-so-c101-in-mice-at-2020-aacr-virtual-annual-meeting-ii
SOTIO Presents New Data Showing Strong Anti-tumor Effect of IL-15 Superagonist SO-C101 in Mice at 2020 AACR Virtual Annual Meeting II
Published on 22/06/2020, 09:00 | 12521hits
happy-25-years-anniversary-and-a-new-era-of-pharma-partnering
Happy 25-Years Anniversary And a New Era of Pharma Partnering
Published on 16/06/2020, 09:00 | 12803hits
arivis-unveils-multiuser-vr-for-volumetric-imaging
arivis Unveils Multiuser VR For Volumetric Imaging
Published on 15/06/2020, 14:00 | 12377hits
sotio-to-present-new-preclinical-data-on-il-15-superagonist-so-c101-at-the-2020-aacr-virtual-annual-meeting-ii
SOTIO to Present New Preclinical Data on IL-15 Superagonist, SO-C101, at the 2020 AACR Virtual Annual Meeting II
Published on 12/06/2020, 09:30 | 13296hits
zz-biotech-announces-fda-fast-track-designation-for-stroke-program
ZZ Biotech Announces FDA Fast Track Designation for Stroke Program
Published on 08/06/2020, 09:30 | 13580hits
ophthalmic-digital-health-implandata-launches-eyemate-iop-tracking-service-for-remote-monitoring-and-improved-glaucoma-care
Ophthalmic Digital Health: Implandata Launches EYEMATE IOP-Tracking Service for Remote Monitoring and Improved Glaucoma Care
Published on 05/06/2020, 10:30 | 12789hits
cellbox-solutions-appoints-dr-herbert-mueller-hartmann-as-head-of-research-and-development
Cellbox Solutions Appoints Dr. Herbert Mueller-Hartmann as Head of Research and Development
Published on 02/06/2020, 14:00 | 12757hits
delta-4-announces-results-achieved-with-drug-discovery-platform
Delta 4 Announces Results Achieved with Drug Discovery Platform
Published on 28/05/2020, 16:15 | 12537hits
vetter-wins-axia-best-managed-companies-award
Vetter Wins Axia Best Managed Companies Award
Published on 28/05/2020, 09:00 | 14895hits
irbm-s-advent-announces-manufacture-of-13-000-doses-of-covid-19-vaccine-for-use-in-phase-2-3-clinical-trials-by-the-university-of-oxford
IRBM’s Advent Announces Manufacture of 13,000 Doses of Covid-19 Vaccine, for Use in Phase 2/3 Clinical Trials by the University of Oxford
Published on 26/05/2020, 09:00 | 12723hits
seranovo-enters-into-a-second-license-agreement-with-carna-biosciences-for-development-of-oral-formulation-of-carna-s-kinase-inhibitor
SeraNovo Enters into a Second License Agreement with Carna Biosciences for Development of Oral Formulation of Carna’s Kinase Inhibitor
Published on 21/05/2020, 11:00 | 12853hits
shuwen-announces-peer-reviewed-publication-of-data-demonstrating-the-potential-of-its-breakthrough-preeclampsia-detection-device-in-unselected-women
Shuwen Announces Peer-Reviewed Publication of Data Demonstrating the Potential of its Breakthrough Preeclampsia Detection Device in Unselected Women
Published on 20/05/2020, 15:00 | 13117hits
airway-therapeutics-and-celonic-group-collaborate-to-produce-at-100-as-promising-new-candidate-for-coronavirus
Airway Therapeutics and Celonic Group Collaborate to Produce AT-100 as Promising New Candidate for Coronavirus
Published on 19/05/2020, 18:00 | 14260hits
bc-platforms-and-kaiser-permanente-win-2020-microsoft-health-innovation-award-for-precision-medicine-collaboration
BC Platforms and Kaiser Permanente Win 2020 Microsoft Health Innovation Award for Precision Medicine Collaboration
Published on 18/05/2020, 10:00 | 13201hits
fluoguide-a-s-is-awarded-best-ipo-in-2019-by-the-independent-ipo-guide
FluoGuide A/S is Awarded Best IPO in 2019 by the Independent IPO Guide
Published on 14/05/2020, 09:00 | 17068hits
clinigen-signs-exclusive-agreement-with-xeris-pharmaceuticals-to-supply-and-distribute-gvoke-outside-the-us
Clinigen Signs Exclusive Agreement with Xeris Pharmaceuticals to Supply and Distribute Gvoke™ Outside the US
Published on 13/05/2020, 10:00 | 13075hits
biomed-x-institute-launches-rapid-antiviral-response-platform-to-prevent-future-pandemics
BioMed X Institute Launches Rapid Antiviral Response Platform to Prevent Future Pandemics
Published on 13/05/2020, 09:00 | 12410hits
polyganics-awarded-1-2-million-for-clinical-development-of-liver-and-pancreas-sealant-patch
Polyganics Awarded €1.2 Million for Clinical Development of Liver and Pancreas Sealant Patch
Published on 11/05/2020, 13:00 | 13914hits
hitachi-chemical-advanced-therapeutics-solutions-and-apceth-biopharma-gmbh-enter-into-strategic-clinical-and-commercial-manufacturing-agreements-with-bluebird-bio
Hitachi Chemical Advanced Therapeutics Solutions and apceth Biopharma GmbH Enter into Strategic Clinical and Commercial Manufacturing Agreements with bluebird bio
Published on 05/05/2020, 09:00 | 13364hits
d-flex-a-new-generation-of-manual-injection-pens-from-haselmeier-wins-red-dot-for-outstanding-design-quality
D-Flex® a New Generation of Manual Injection Pens from Haselmeier Wins Red Dot for Outstanding Design Quality
Published on 28/04/2020, 16:00 | 13673hits
probiogen-ag-appoints-dr-lutz-hilbrich-as-new-chief-executive-officer-dr-wieland-wolf-retires
ProBioGen AG Appoints Dr. Lutz Hilbrich as New Chief Executive Officer - Dr. Wieland Wolf Retires
Published on 27/04/2020, 10:00 | 13465hits
artes-joins-global-combat-against-corona
ARTES Joins Global Combat against Corona
Published on 23/04/2020, 09:00 | 13608hits
noscendo-closes-series-a-financing-and-launches-disqver-in-europe-to-significantly-improve-diagnosis-of-infectious-diseases
Noscendo Closes Series A Financing and Launches DISQVER® in Europe to Significantly Improve Diagnosis of Infectious Diseases
Published on 21/04/2020, 16:45 | 13340hits
vetter-s-high-performance-is-again-recognized-at-the-2020-cmo-leadership-awards
Vetter’s High Performance Is Again Recognized at the 2020 CMO Leadership Awards
Published on 16/04/2020, 11:00 | 13978hits
synthon-biopharmaceuticals-relaunches-as-byondis
Synthon Biopharmaceuticals Relaunches as Byondis
Published on 15/04/2020, 14:30 | 13306hits
europlx-73-vienna-pharma-partnering-conference-postponed
euroPLX 73 Vienna Pharma Partnering Conference Postponed
Published on 15/04/2020, 13:30 | 14851hits
halix-enters-collaboration-with-the-university-of-oxford-for-gmp-manufacturing-of-a-covid-19-vaccine
HALIX Enters Collaboration with the University of Oxford for GMP Manufacturing of a COVID-19 Vaccine
Published on 27/03/2020, 09:00 | 14921hits
immune-regulation-ltd-appoints-jonathan-rigby-as-chief-executive-officer
Immune Regulation Ltd Appoints Jonathan Rigby as Chief Executive Officer
Published on 25/03/2020, 13:00 | 14918hits
sartorius-supports-the-development-of-the-first-vaccine-candidate-against-the-novel-coronavirus-to-enter-clinical-trials
Sartorius Supports the Development of the First Vaccine Candidate Against the Novel Coronavirus to Enter Clinical Trials
Published on 25/03/2020, 09:00 | 14157hits
evitria-crosses-100-citation-threshold
evitria Crosses 100-Citation Threshold
Published on 24/03/2020, 16:00 | 15038hits
immunogenesis-contracts-probiogen-for-development-and-large-scale-manufacturing-services
Immunogenesis Contracts ProBioGen for Development and Large-Scale Manufacturing Services
Published on 23/03/2020, 09:00 | 15636hits
vaccitech-and-oxford-university-announce-promising-phase-2a-data-on-prostate-cancer-immunotherapy
Vaccitech and Oxford University Announce Promising Phase 2a Data on Prostate Cancer Immunotherapy
Published on 17/03/2020, 09:00 | 15217hits
haselmeier-receives-medical-device-master-file-number-for-d-flex-product-platform
Haselmeier Receives Medical Device Master File Number for D-Flex Product Platform
Published on 13/03/2020, 14:00 | 18623hits
deuterium-depletion-as-a-possible-new-strategy-to-combat-sars-cov-2
Deuterium Depletion as a Possible New Strategy to Combat SARS-CoV-2
Published on 12/03/2020, 14:00 | 14896hits
toxys-raises-2-million-financing-for-global-expansion-of-its-unique-animal-free-chemical-safety-tests
Toxys Raises €2 Million Financing for Global Expansion of its Unique Animal-Free Chemical Safety Tests
Published on 10/03/2020, 09:00 | 14727hits
paradigm-shift-in-angiography-kinepict-medical-imaging-technology-kmit-receives-us-fda-510-k-clearance
Paradigm Shift in Angiography: Kinepict Medical Imaging Technology (KMIT) Receives US FDA 510(K) Clearance
Published on 09/03/2020, 12:00 | 18667hits
sartorius-launches-biostat-str-generation-3-with-biobrain-making-biopharmaceutical-development-and-production-faster-simpler-and-safer
Sartorius Launches BIOSTAT STR® Generation 3 with BIOBRAIN - Making Biopharmaceutical Development and Production Faster, Simpler and Safer
Published on 03/03/2020, 14:00 | 14765hits
mimetas-to-launch-assay-ready-product-line-for-organ-on-a-chip
MIMETAS to Launch Assay Ready Product Line for Organ-on-a-Chip
Published on 02/03/2020, 10:00 | 17627hits
completion-of-study-enrolment-of-implandata-s-extraocular-eye-pressure-sensor-for-continual-glaucoma-monitoring
Completion of Study Enrolment of Implandata’s Extraocular Eye Pressure Sensor for Continual Glaucoma Monitoring
Published on 25/02/2020, 11:00 | 20222hits
securecell-partners-with-alit-life-science-biofors-global-inc-and-danyel-biotech-as-marketing-sales-partners-in-china-south-korea-and-israel
Securecell Partners with Alit Life Science, Biofors Global Inc. and Danyel Biotech as Marketing & Sales Partners in China, South Korea and Israel
Published on 25/02/2020, 10:00 | 15111hits
immunos-therapeutics-selects-probiogen-for-development-and-large-scale-manufacturing-services
ImmunOs Therapeutics Selects ProBioGen for Development and Large-Scale Manufacturing Services
Published on 25/02/2020, 09:00 | 14904hits
wolfgang-kintzel-to-become-cellbox-solutions-ceo
Wolfgang Kintzel to Become Cellbox Solutions’ CEO
Published on 24/02/2020, 18:00 | 14588hits
shuwen-biotech-to-offer-breakthrough-preeclampsia-detection-device-globally-through-collaboration-with-perkinelmer
Shuwen Biotech to Offer Breakthrough Preeclampsia Detection Device Globally through Collaboration with PerkinElmer
Published on 24/02/2020, 12:00 | 14653hits
sartorius-introduces-biopat-spectro-to-enable-raman-spectroscopy-capability-and-qbd-with-its-ambr-and-biostat-str-platforms
Sartorius Introduces BioPAT® Spectro to Enable Raman Spectroscopy Capability and QbD with its ambr® and BIOSTAT STR® Platforms
Published on 18/02/2020, 14:30 | 14577hits
good-laboratory-practices-software-upgrade-for-biotage-extrahera
Good Laboratory Practices Software Upgrade for Biotage® Extrahera™
Published on 11/02/2020, 10:00 | 17301hits
bd-completes-clinical-trial-for-bd-libertas-wearable-injector
BD Completes Clinical Trial for BD Libertas™ Wearable Injector
Published on 03/02/2020, 14:00 | 16362hits
raucon-pharma-partnering-conferences-limit-attendance-for-more-value
RauCon Pharma Partnering Conferences Limit Attendance For More Value
Published on 30/01/2020, 15:45 | 16911hits
vetter-aligns-its-development-service-laboratory-portfolio-under-one-roof
Vetter Aligns its Development Service Laboratory Portfolio Under One Roof
Published on 28/01/2020, 15:45 | 17107hits
saga-diagnostics-extends-its-collaboration-with-servier-to-use-ultrasensitive-sagasafe-technology-in-cancer-clinical-trials
SAGA Diagnostics Extends its Collaboration with Servier to Use Ultrasensitive SAGAsafe® Technology in Cancer Clinical Trials
Published on 27/01/2020, 13:00 | 18701hits
bionetix-proqinase-and-mercachemsyncom-announce-a-joint-research-project-from-target-identification-to-clinical-study
Bionetix, ProQinase, and MercachemSyncom Announce a Joint Research Project from Target Identification to Clinical Study
Published on 27/01/2020, 09:00 | 16044hits
noscendo-expands-proprietary-diagnostic-platform-disqver-to-include-microbial-resistances-in-partnership-with-university-hospital-bonn
Noscendo Expands Proprietary Diagnostic Platform DISQVER to Include Microbial Resistances in Partnership with University Hospital Bonn
Published on 23/01/2020, 09:00 | 17785hits
wise-completes-enrolment-in-pivotal-clinical-study-of-novel-neuro-electrodes-for-brain-monitoring
WISE Completes Enrolment in Pivotal Clinical Study of Novel Neuro-Electrodes for Brain Monitoring
Published on 21/01/2020, 14:00 | 17749hits
toxys-strengthens-leadership-team-with-appointment-of-cbo-and-coo-positions
Toxys Strengthens Leadership Team with Appointment of CBO and COO Positions
Published on 21/01/2020, 11:00 | 18250hits
bioprocessing-summit-europe-returns-march-24-26-2020-in-barcelona-with-new-analytical-and-formulation-sessions
Bioprocessing Summit Europe Returns March 24-26, 2020 in Barcelona with New Analytical and Formulation Sessions
Published on 21/01/2020, 09:00 | 17686hits
heparegenix-gmbh-secures-series-b-financing-in-excess-of-11-mio-to-advance-first-drug-candidate-to-the-clinic
HepaRegeniX GmbH Secures Series B Financing in Excess of €11 Mio. to Advance First Drug Candidate to the Clinic
Published on 20/01/2020, 12:00 | 15929hits
osteolabs-gmbh-successfully-closes-first-international-commercial-agreements-and-starts-contract-research-collaboration-with-the-health-department-of-an-european-army
Osteolabs GmbH Successfully Closes First International Commercial Agreements and Starts Contract Research Collaboration with the Health Department of an European Army
Published on 14/01/2020, 10:00 | 18501hits
probiogen-and-lava-therapeutics-sign-cell-line-development-and-gmp-manufacturing-agreement-for-novel-bispecific-molecule
ProBioGen and Lava Therapeutics Sign Cell Line Development and GMP Manufacturing Agreement for Novel Bispecific Molecule
Published on 13/01/2020, 16:00 | 18722hits
biomed-x-starts-new-schizophrenia-research-program-with-boehringer-ingelheim
BioMed X Starts New Schizophrenia Research Program with Boehringer Ingelheim
Published on 13/01/2020, 12:00 | 19117hits
apceth-starts-commercial-manufacturing-of-zynteglo-bluebird-bio-s-gene-therapy-for-transfusion-dependent-ce-b2-thalassemia
apceth Starts Commercial Manufacturing of Zynteglo™ ▼, bluebird bio’s Gene Therapy for Transfusion-Dependent β-Thalassemia
Published on 10/01/2020, 09:00 | 19057hits
nbe-therapeutics-closes-usd-22m-series-c-financing-round
NBE-Therapeutics Closes USD 22M Series C Financing Round
Published on 09/01/2020, 12:00 | 17985hits
raucon-kicks-off-2020-with-singapore-airlines-served-asian-pharma-partnering-event
RauCon Kicks Off 2020 With Singapore Airlines Served Asian Pharma Partnering Event
Published on 09/01/2020, 11:00 | 17162hits
biomed-x-starts-new-research-program-in-autoimmune-diseases-with-merck
BioMed X Starts New Research Program in Autoimmune Diseases with Merck
Published on 08/01/2020, 12:00 | 17461hits
sotio-opens-office-in-basel-switzerland-to-accelerate-development-of-its-pipeline-products
SOTIO Opens Office in Basel, Switzerland, to Accelerate Development of its Pipeline Products
Published on 08/01/2020, 10:00 | 16848hits
probiogen-inks-next-commercial-glymaxx-license-with-roche
ProBioGen Inks Next Commercial GlymaxX® License with Roche
Published on 08/01/2020, 09:00 | 16434hits
selonterra-announces-presentation-of-alzheimer-s-disease-therapy-program-at-biotech-showcase-2020-in-san-francisco
Selonterra Announces Presentation of Alzheimer’s Disease Therapy Program at Biotech Showcase™ 2020 in San Francisco
Published on 07/01/2020, 09:00 | 16712hits
polyganics-achieves-ce-mark-certification-for-liqoseal
Polyganics Achieves CE Mark Certification for LIQOSEAL®
Published on 07/01/2020, 07:30 | 16503hits
velabs-therapeutics-receives-exclusive-licence-from-alytas-therapeutics-for-the-development-of-therapeutic-antibodies-as-senolytics
Velabs Therapeutics Receives Exclusive Licence from Alytas Therapeutics for the Development of Therapeutic Antibodies as Senolytics
Published on 19/12/2019, 12:30 | 18509hits
aglaia-oncology-funds-and-sinzer-grant-thornton-launch-dedicated-life-sciences-impact-measuring-and-reporting-suite
Aglaia Oncology Funds and Sinzer - Grant Thornton Launch Dedicated Life Sciences Impact Measuring and Reporting Suite
Published on 19/12/2019, 11:00 | 40378hits
sartorius-and-the-german-research-center-for-artificial-intelligence-launch-joint-research-laboratory
Sartorius and the German Research Center for Artificial Intelligence Launch Joint Research Laboratory
Published on 18/12/2019, 15:15 | 18250hits
sartorius-establishes-scientific-advisory-board
Sartorius Establishes Scientific Advisory Board
Published on 18/12/2019, 15:00 | 16170hits
mc2-therapeutics-announces-positive-top-line-results-from-eu-phase-3-head-to-head-trial-comparing-wynzora-cream-to-daivobet-gel-in-patients-with-psoriasis
MC2 Therapeutics Announces Positive Top-line Results from EU Phase 3 Head-to-Head Trial Comparing Wynzora™ Cream to Daivobet® Gel in Patients with Psoriasis
Published on 18/12/2019, 09:00 | 15416hits
vaccitech-oncology-limited-enters-collaboration-with-cancer-research-uk-to-fund-a-phase-i-iia-clinical-trial-as-first-line-nsclc-therapy
Vaccitech Oncology Limited Enters Collaboration with Cancer Research UK to Fund a Phase I/IIa Clinical Trial as First-Line NSCLC Therapy
Published on 18/12/2019, 08:00 | 18647hits
bc-platforms-closes-15-million-series-c-financing-and-signs-partnership-with-iqvia-to-extend-data-analytics-in-genomics
BC Platforms Closes $15 Million Series C Financing and Signs Partnership with IQVIA to Extend Data Analytics in Genomics
Published on 17/12/2019, 11:00 | 14985hits
cellestia-biotech-ag-successfully-closes-series-b-financing-round-raising-a-total-of-chf-20-million-guido-guidi-elected-new-chairman-of-the-board-of-directors-and-robert-karsunky-elected-new-chairman-of-the-audit-committee-and-board-of-directors-member
Cellestia Biotech AG Successfully Closes Series B Financing Round, Raising a Total of CHF 20 Million. Guido Guidi Elected New Chairman of the Board of Directors and Robert Karsunky Elected New Chairman of the Audit Committee and Board of Directors Member.
Published on 17/12/2019, 09:30 | 15817hits
abcam-and-somaserve-announce-comprehensive-partnership-to-realise-the-potential-of-polynaut-bionic-nanoparticles-for-delivery-to-live-cells
Abcam and SomaServe Announce Comprehensive Partnership to Realise the Potential of PolyNaut® 'Bionic' Nanoparticles for Delivery to Live Cells
Published on 10/12/2019, 15:10 | 17172hits
vetter-s-occupational-health-management-excels-again-in-employee-wellness-initiatives
Vetter's Occupational Health Management Excels Again in Employee Wellness Initiatives
Published on 09/12/2019, 17:30 | 20378hits
metp-pharma-receives-us-patent-for-drug-therapy-of-demyelinating-and-neuroinflammatory-diseases-such-as-multiple-sclerosis
MetP Pharma Receives US Patent for Drug Therapy of Demyelinating and Neuroinflammatory Diseases such as Multiple Sclerosis
Published on 02/12/2019, 11:00 | 18642hits
biomed-x-reaches-milestone-in-respiratory-disease-research-collaboration-with-boehringer-ingelheim
BioMed X Reaches Milestone in Respiratory Disease Research Collaboration with Boehringer Ingelheim
Published on 25/11/2019, 09:00 | 19530hits
vaccitech-provides-update-on-clinical-progress-for-its-two-phase-2-universal-influenza-studies
Vaccitech Provides Update on Clinical Progress for its Two Phase 2 Universal Influenza Studies
Published on 22/11/2019, 14:00 | 19303hits
halix-celebrates-grand-opening-of-its-state-of-the-art-cgmp-facility
HALIX Celebrates Grand Opening of its State-of-the-Art cGMP Facility
Published on 21/11/2019, 10:00 | 19518hits
mc2-therapeutics-announces-fda-acceptance-of-its-new-drug-application-for-wynzora-cream-for-treatment-of-plaque-psoriasis
MC2 Therapeutics Announces FDA Acceptance of its New Drug Application for Wynzora™ Cream for Treatment of Plaque Psoriasis
Published on 18/11/2019, 09:00 | 19167hits
securecell-introduces-sephara-a-novel-silicon-based-in-situ-filtration-membrane
Securecell Introduces Sephara, a Novel, Silicon-Based In-Situ Filtration Membrane
Published on 12/11/2019, 10:00 | 18459hits
directedluck-a-transposase-for-efficient-gene-delivery-and-high-titer-cell-line-development
DirectedLuck, a Transposase for Efficient Gene Delivery and High-Titer Cell Line Development
Published on 12/11/2019, 09:00 | 24360hits
zontal-space-disruptive-technologies-pave-the-path-to-the-lab-of-the-future
ZONTAL Space – Disruptive Technologies Pave the Path to the Lab of the Future
Published on 11/11/2019, 09:00 | 19476hits
evitria-opens-its-new-head-office-in-scandinavia
evitria Opens its New Head Office in Scandinavia
Published on 08/11/2019, 07:00 | 17294hits
abcam-and-brickbio-announce-a-partnership-to-incorporate-conjugation-ready-sites-into-recombinant-antibodies-across-abcam-s-portfolio
Abcam and BrickBio Announce a Partnership to Incorporate Conjugation-Ready Sites into Recombinant Antibodies Across Abcam’s Portfolio
Published on 07/11/2019, 11:00 | 17401hits
sotio-exercises-second-target-option-under-existing-collaboration-with-nbe-therapeutics-to-develop-next-generation-antibody-drug-conjugates
SOTIO Exercises Second Target Option Under Existing Collaboration with NBE-Therapeutics to Develop Next-Generation Antibody-Drug Conjugates
Published on 05/11/2019, 09:00 | 20079hits
scirhom-initiates-first-in-class-antibody-development-program-to-treat-major-autoimmune-diseases
SciRhom Initiates First-In-Class Antibody Development Program to Treat Major Autoimmune Diseases
Published on 04/11/2019, 14:00 | 19321hits
ichnos-sciences-announces-completion-of-enrollment-of-phase-2b-trials-for-two-investigational-therapies-isb-830-and-isc-27864
Ichnos Sciences Announces Completion of Enrollment of Phase 2b Trials for Two Investigational Therapies - ISB 830 And ISC 27864
Published on 30/10/2019, 17:15 | 19401hits
vetter-provides-greater-flexibility-in-secondary-packaging-through-collaborative-work
Vetter Provides Greater Flexibility in Secondary Packaging Through Collaborative Work
Published on 30/10/2019, 14:00 | 19087hits
seranovo-enters-into-license-agreement-with-carna-biosciences-for-development-of-oral-formulation-of-carna-s-kinase-inhibitor
SeraNovo Enters into License Agreement with Carna Biosciences for Development of Oral Formulation of Carna's Kinase Inhibitor
Published on 30/10/2019, 09:00 | 20694hits
tsi-reports-enrollment-of-first-10-patients-in-its-phase-2-ischemic-stroke-clinical-trial-and-completion-of-its-phase-2-study-protocol-in-myocardial-infarction
TSI Reports Enrollment of First 10 Patients in its Phase 2 Ischemic Stroke Clinical Trial and Completion of its Phase 2 Study Protocol in Myocardial Infarction
Published on 29/10/2019, 09:00 | 19819hits
bioversys-receives-carb-x-award-of-up-to-us-8-92-million-for-development-of-novel-antimicrobial-therapies
BioVersys Receives CARB-X Award of up to US$ 8.92 Million for Development of Novel Antimicrobial Therapies
Published on 28/10/2019, 13:00 | 18892hits
biomed-x-completes-alzheimer-s-disease-research-project
BioMed X Completes Alzheimer’s Disease Research Project
Published on 23/10/2019, 15:00 | 18395hits
shuwen-biotech-designated-as-an-international-cooperation-base-for-medical-diagnostic-technologies
Shuwen Biotech Designated as an International Cooperation Base for Medical Diagnostic Technologies
Published on 21/10/2019, 14:15 | 19412hits
sartorius-stedim-biotech-launches-new-sartocheck-5-plus-filter-tester
Sartorius Stedim Biotech Launches New Sartocheck® 5 Plus Filter Tester
Published on 21/10/2019, 07:00 | 17191hits
bd-launches-bd-intevia-1ml-two-step-disposable-autoinjector-a-robust-platform-device-combining-autoinjector-and-pre-fillable-syringe-in-one-integrated-system
BD Launches BD Intevia™ 1mL Two-step Disposable Autoinjector – A Robust Platform Device Combining Autoinjector and Pre-Fillable Syringe in One Integrated System
Published on 17/10/2019, 10:00 | 19272hits
heparegenix-gmbh-announces-management-changes
HepaRegeniX GmbH Announces Management Changes
Published on 16/10/2019, 11:00 | 16668hits
amarna-therapeutics-raises-10-million-to-progress-lead-development-candidate-into-clinical-trials-and-appoints-a-new-supervisory-board
Amarna Therapeutics Raises €10 Million to Progress Lead Development Candidate into Clinical Trials and Appoints a New Supervisory Board
Published on 14/10/2019, 13:45 | 18655hits
ppf-and-sotio-invest-6-5-million-in-maverix-oncology-and-its-lead-program-mvx-5005
PPF and SOTIO Invest $6.5 Million in MaveriX Oncology and its Lead Program MVX-5005
Published on 11/10/2019, 12:15 | 19032hits
ime-medical-electrospinning-appoints-three-seasoned-medtech-and-biopharmeutical-industry-experts-to-its-board-of-directors
IME Medical Electrospinning Appoints Three Seasoned Medtech and Biopharmeutical Industry Experts to its Board of Directors
Published on 10/10/2019, 09:00 | 18935hits
clinigen-launches-managed-access-program-for-progenics-pharmaceuticals-for-azedra-outside-the-us
Clinigen Launches Managed Access Program for Progenics Pharmaceuticals for AZEDRA® Outside the US
Published on 08/10/2019, 11:00 | 18703hits
nbe-therapeutics-appoints-dr-steffen-heeger-as-chief-medical-officer-for-leading-the-clinical-development-of-nbe-s-iadc-programs
NBE-Therapeutics Appoints Dr. Steffen Heeger as Chief Medical Officer for Leading The Clinical Development of NBE’s iADC Programs
Published on 07/10/2019, 14:15 | 16458hits
haselmeier-signs-an-exclusive-agreement-with-stevanato-group-to-license-axis-d-pen-injector-technology-and-intellectual-property-for-the-therapeutic-area-of-diabetes-care
Haselmeier Signs an Exclusive Agreement with Stevanato Group to License Axis-D Pen-injector Technology and Intellectual Property for the Therapeutic Area of Diabetes Care
Published on 01/10/2019, 10:00 | 16601hits
probiogen-and-ceva-sante-animale-sign-an-exclusive-license-agreement-to-produce-vectorised-poultry-vaccines-using-age1-cr-production-technology
ProBioGen and Ceva Santé Animale Sign an Exclusive License Agreement to Produce Vectorised Poultry Vaccines Using AGE1.CR® Production Technology
Published on 01/10/2019, 09:30 | 19022hits
mimetas-and-hubrecht-organoid-technologies-to-develop-and-market-organoids-on-a-chip
MIMETAS and Hubrecht Organoid Technologies to Develop and Market Organoids-on-a-Chip
Published on 26/09/2019, 16:30 | 20565hits
genewiz-celebrates-opening-of-european-headquarters-in-germany
GENEWIZ Celebrates Opening of European Headquarters in Germany
Published on 26/09/2019, 10:00 | 20446hits
closing-of-financing-round-and-strengthening-of-development-team-paves-the-way-for-t3-pharma-to-enter-the-clinic
Closing of Financing Round and Strengthening of Development Team Paves the Way for T3 Pharma to Enter the Clinic
Published on 25/09/2019, 10:00 | 19124hits
nst-doses-first-patient-in-phase-2b-clinical-study-of-icosabutate-in-nash-icona
NST Doses First Patient in Phase 2b Clinical Study of Icosabutate in NASH (‘ICONA’)
Published on 23/09/2019, 09:00 | 18607hits
biomed-x-successfully-completes-collaboration-on-development-of-nanomaterial-based-biosensors-for-near-patient-testing
BioMed X Successfully Completes Collaboration on Development of Nanomaterial-based Biosensors for Near-patient Testing
Published on 19/09/2019, 17:30 | 18810hits
mimetas-chairman-of-the-board-herbert-heyneker-receives-dutch-royal-honor
Mimetas Chairman of the Board Herbert Heyneker Receives Dutch Royal Honor
Published on 18/09/2019, 17:10 | 18993hits
vetter-s-chicago-site-wins-award-one-of-best-and-brightest-companies-to-work-for
Vetter’s Chicago Site Wins Award ‘One of Best and Brightest Companies to Work For®’
Published on 17/09/2019, 09:00 | 18850hits
polyganics-achieves-positive-3-month-follow-up-data-of-encase-i-the-first-clinical-trial-for-liqoseal
Polyganics Achieves Positive 3-month Follow-up Data of ENCASE I, the First Clinical Trial for LIQOSEAL®
Published on 16/09/2019, 15:10 | 17558hits
ppf-expands-its-investment-in-the-healthcare-sector-through-acquisition-of-significant-stake-in-t-cell-therapy-company-autolus-therapeutics
PPF Expands its Investment in the Healthcare Sector Through Acquisition of Significant Stake in T Cell Therapy Company Autolus Therapeutics
Published on 10/09/2019, 10:00 | 19123hits
probiogen-licenses-glymaxx-technology-to-bayer
ProBioGen Licenses GlymaxX® Technology to Bayer
Published on 10/09/2019, 09:30 | 16429hits
noscendo-reaches-ce-certification-as-key-milestone-for-its-proprietary-diagnostic-platform-disqver-and-conducts-successful-piloting-in-eight-maximum-care-hospitals
Noscendo Reaches CE Certification as Key Milestone for its Proprietary Diagnostic Platform DISQVER® and Conducts Successful Piloting in Eight Maximum Care Hospitals
Published on 30/08/2019, 09:00 | 20692hits
mario-polywka-joins-orbit-discovery-s-board-of-directors
Mario Polywka Joins Orbit Discovery’s Board of Directors
Published on 28/08/2019, 09:00 | 17238hits
rfxcel-the-global-leader-in-track-and-trace-solutions-continues-rapid-growth-in-russia-doubling-the-size-of-its-team-entering-new-industries
rfxcel, the Global Leader in Track and Trace Solutions, Continues Rapid Growth in Russia, Doubling the Size of Its Team, Entering New Industries
Published on 27/08/2019, 10:00 | 17911hits
velabs-therapeutics-enters-into-a-screening-cooperation-with-chiome-bioscience-in-the-field-of-gpcr-specific-functional-antibody-screening-after-successful-feasibility-study
Velabs Therapeutics Enters into a Screening Cooperation with Chiome Bioscience in the Field of GPCR-Specific Functional Antibody Screening After Successful Feasibility Study
Published on 27/08/2019, 09:00 | 20978hits
vaccitech-appoints-bill-enright-as-new-chief-executive-officer
Vaccitech Appoints Bill Enright as New Chief Executive Officer
Published on 22/08/2019, 11:00 | 19382hits
rfxcel-will-exhibit-at-cphi-middle-east-africa-the-largest-pharmaceutical-event-in-the-region
rfxcel Will Exhibit at CPhI Middle East & Africa, the Largest Pharmaceutical Event in the Region
Published on 22/08/2019, 09:00 | 19163hits
denovomatrix-introduces-ready-to-use-chemically-defined-coated-cell-cultureware-for-serum-free-hmsc-expansion
denovoMATRIX Introduces Ready-To-Use, Chemically Defined Coated Cell Cultureware for Serum-Free hMSC Expansion
Published on 21/08/2019, 17:00 | 17267hits
atelerix-consortium-awarded-267-000-innovate-uk-grant-for-collaboration-with-the-cell-and-gene-therapy-catapult-and-rexgenero-on-cell-therapy-stabilisation-technologies
Atelerix Consortium Awarded £267,000 Innovate UK Grant for Collaboration with the Cell and Gene Therapy Catapult and Rexgenero on Cell Therapy Stabilisation Technologies
Published on 09/08/2019, 10:00 | 20027hits
halix-starts-operational-production-with-new-cgmp-facility-in-q4-2019
HALIX Starts Operational Production with New cGMP Facility in Q4-2019
Published on 08/08/2019, 11:00 | 20616hits
sartorius-stedim-biotech-launches-new-services-for-mammalian-cell-bank-manufacturing
Sartorius Stedim Biotech Launches New Services for Mammalian Cell Bank Manufacturing
Published on 05/08/2019, 16:45 | 20633hits
cytena-gmbh-announces-that-it-has-been-entered-into-an-agreement-to-be-acquired-by-cellink
Cytena GmbH Announces That It Has Been Entered into an Agreement to Be Acquired by CELLINK
Published on 31/07/2019, 09:00 | 17976hits
results-of-the-pivotal-phase-3-study-of-the-bempedoic-acid-ezetimibe-combination-tablet-published-in-the-european-journal-of-preventative-cardiology-demonstrated-significant-ldl-c-lowering
Results of the Pivotal Phase 3 Study of the Bempedoic Acid / Ezetimibe Combination Tablet Published in the European Journal of Preventative Cardiology Demonstrated Significant LDL-C Lowering
Published on 23/07/2019, 09:00 | 21325hits
cytena-founds-subsidiary-in-taiwan
Cytena Founds Subsidiary in Taiwan
Published on 11/07/2019, 12:00 | 22064hits
sotio-initiates-first-in-human-clinical-trial-with-il-15-superagonist-so-c101
SOTIO Initiates First-In-Human Clinical Trial with IL-15 Superagonist SO-C101
Published on 08/07/2019, 14:15 | 22269hits
prestige-biopharma-releases-positive-results-from-phase-i-study-of-hd204-biosimilar-candidate-to-bevacizumab
Prestige BioPharma Releases Positive Results from Phase I Study of HD204, Biosimilar Candidate to Bevacizumab
Published on 08/07/2019, 09:00 | 19437hits
prestige-biopharma-and-pharmapark-announce-license-and-supply-agreement-to-commercialize-prestige-s-trastuzumab-biosimilar-in-the-russian-federation
Prestige Biopharma and Pharmapark Announce License and Supply Agreement to Commercialize Prestige's Trastuzumab Biosimilar in the Russian Federation
Published on 03/07/2019, 09:00 | 22176hits
confo-therapeutics-and-dynabind-announce-drug-discovery-collaboration-to-identify-novel-gpcr-modulating-compounds
Confo Therapeutics and DyNAbind Announce Drug Discovery Collaboration to Identify Novel GPCR-Modulating Compounds
Published on 28/06/2019, 13:30 | 21417hits
new-biotage-vacmaster-disk-vacuum-extraction-with-rugged-versatility
New Biotage® VacMaster™ Disk - Vacuum Extraction with Rugged Versatility
Published on 27/06/2019, 13:30 | 21245hits
velabs-therapeutics-announces-3-million-series-b-financing-to-advance-its-functional-antibody-screening-programme
Velabs Therapeutics Announces €3 Million Series B Financing to Advance its Functional Antibody Screening Programme
Published on 27/06/2019, 11:00 | 21804hits
new-ambr-250-modular-bioreactor-vessel-launched-for-cell-and-gene-therapy-applications
New ambr® 250 Modular Bioreactor Vessel Launched for Cell and Gene Therapy Applications
Published on 26/06/2019, 17:15 | 18627hits
mammaprint-becomes-only-molecular-diagnostic-recommended-for-early-stage-node-positive-breast-cancer-patients-in-asco-endorsed-cancer-care-ontario-guidelines
MammaPrint® Becomes Only Molecular Diagnostic Recommended for Early-Stage Node-Positive Breast Cancer Patients in ASCO-Endorsed Cancer Care Ontario Guidelines
Published on 24/06/2019, 11:00 | 23045hits
prestige-biopharma-reports-positive-top-line-phase-iii-results-for-tuznue-trastuzumab-biosimilar
Prestige BioPharma Reports Positive Top-Line Phase III Results for Tuznue® (Trastuzumab Biosimilar)
Published on 24/06/2019, 08:00 | 21594hits
clinigen-broadens-partnership-with-accord-healthcare-to-supply-and-distribute-cardioxane-and-savene-in-poland
Clinigen Broadens Partnership with Accord Healthcare to Supply and Distribute Cardioxane® and Savene® in Poland
Published on 20/06/2019, 14:00 | 17731hits
agendia-announces-publication-of-study-validating-use-of-mammaprint-and-blueprint-molecular-diagnostics-using-targeted-rna-next-generation-sequencing-technology
Agendia Announces Publication of Study Validating Use of MammaPrint and BluePrint Molecular Diagnostics using Targeted RNA Next-Generation Sequencing Technology
Published on 17/06/2019, 17:00 | 20333hits
phase-2-trial-shows-efficacy-of-cytuvax-s-adjuvant-platform-technology
Phase 2 Trial Shows Efficacy of CyTuVax’s Adjuvant Platform Technology
Published on 17/06/2019, 09:00 | 20149hits
osteolabs-gmbh-successfully-closes-seed-financing-round
Osteolabs GmbH Successfully Closes Seed Financing Round
Published on 11/06/2019, 14:00 | 21011hits
saga-raises-40-million-sek-3-7-million-to-advance-ultrasensitive-cancer-liquid-biopsies
SAGA Raises 40 Million SEK (€3.7 Million) To Advance Ultrasensitive Cancer Liquid Biopsies
Published on 05/06/2019, 14:45 | 20229hits
arivis-presents-the-new-vision4d-3-1-release-for-working-with-multi-dimensional-big-image-data
arivis Presents the New Vision4D 3.1 Release for Working with Multi-Dimensional Big Image Data
Published on 04/06/2019, 14:00 | 19371hits
strategic-collaboration-between-biotage-and-yingsheng-on-the-chinese-market-for-clinical-mass-spectrometry-applications
Strategic Collaboration between Biotage and Yingsheng on the Chinese Market for Clinical Mass Spectrometry Applications
Published on 04/06/2019, 08:00 | 19572hits
apceth-will-operate-as-the-commercial-manufacturer-in-europe-for-zynteglo-bluebird-bio-s-gene-therapy-for-thalassemia
apceth Will Operate as the Commercial Manufacturer in Europe for Zynteglo™, bluebird bio’s Gene Therapy for β-Thalassemia
Published on 02/06/2019, 15:00 | 18456hits
sotio-s-dcvac-luca-significantly-improves-survival-in-patients-with-stage-iv-non-small-cell-lung-cancer
SOTIO’s DCVAC/LuCa Significantly Improves Survival in Patients with Stage IV Non-small Cell Lung Cancer
Published on 01/06/2019, 15:00 | 18310hits
blueprint-identifies-genomic-subtypes-for-african-american-breast-cancer-patients-with-low-risk-outcomes
BluePrint® Identifies Genomic Subtypes for African-American Breast Cancer Patients with Low Risk Outcomes
Published on 28/05/2019, 17:10 | 18266hits
vetter-works-towards-a-sustainable-energy-supply
Vetter Works Towards a Sustainable Energy Supply
Published on 28/05/2019, 11:45 | 18152hits
european-medicines-agency-accepts-marketing-authorisation-application-for-prestige-biopharma-s-trastuzumab-biosimilar-hd201-for-review
European Medicines Agency Accepts Marketing Authorisation Application for Prestige BioPharma’s Trastuzumab Biosimilar HD201 for Review
Published on 23/05/2019, 10:00 | 18625hits
probiogen-and-abcuro-signed-glymaxx-improved-cell-line-development-and-gmp-production-agreement
ProBioGen and Abcuro Signed GlymaxX®-Improved Cell Line Development and GMP Production Agreement
Published on 21/05/2019, 20:00 | 18584hits
agendia-and-imegen-announce-an-exclusive-distribution-agreement-for-mammaprint-and-blueprint-in-spain-and-portugal
Agendia and Imegen Announce an Exclusive Distribution Agreement for MammaPrint® and BluePrint® in Spain and Portugal
Published on 21/05/2019, 08:30 | 18371hits
ime-medical-electrospinning-launches-medispin-xl-a-cutting-edge-high-volume-electrospinning-production-platform-for-medical-devices
IME Medical Electrospinning Launches MediSpin XL™, a Cutting-Edge High-Volume Electrospinning Production Platform for Medical Devices
Published on 20/05/2019, 12:00 | 18477hits
sotio-to-present-final-phase-i-ii-dcvac-luca-data-at-asco-2019-annual-meeting
SOTIO to Present Final Phase I/II DCVAC/LuCa Data at ASCO 2019 Annual Meeting
Published on 17/05/2019, 08:00 | 15923hits
cristal-therapeutics-to-present-data-at-the-american-society-of-clinical-oncology-asco-2019-annual-meeting-on-lead-clinical-candidate-cpc634-in-patients-with-solid-tumors
Cristal Therapeutics to Present Data at the American Society of Clinical Oncology (ASCO) 2019 Annual Meeting on Lead Clinical Candidate CPC634 in Patients With Solid Tumors
Published on 15/05/2019, 10:00 | 18165hits
probiogen-and-vaccitech-sign-license-agreement-for-probiogen-s-technology-platform
ProBioGen and Vaccitech Sign License Agreement for ProBioGen’s Technology Platform
Published on 14/05/2019, 09:00 | 23428hits
sensid-inks-distribution-agreement-with-tataa-biocenter-for-its-mdx-reference-standards
SensID Inks Distribution Agreement with TATAA Biocenter for its MDx Reference Standards
Published on 09/05/2019, 12:15 | 18986hits
new-ultra-convenient-solid-phase-extraction-disks-from-biotage
New Ultra Convenient Solid Phase Extraction Disks from Biotage
Published on 08/05/2019, 11:00 | 19351hits
sartorius-stedim-biotech-introduces-new-simca-16-software-for-multivariate-data-analytics
Sartorius Stedim Biotech Introduces New SIMCA® 16 Software for Multivariate Data Analytics
Published on 07/05/2019, 11:50 | 17896hits
esact-inaugural-innovation-award-to-honor-probiogen-s-cso-dr-volker-sandig
ESACT Inaugural Innovation Award to Honor ProBioGen’s CSO Dr. Volker Sandig
Published on 07/05/2019, 10:00 | 18998hits
wise-enrols-first-patient-in-pivotal-clinical-study-of-novel-neuro-electrodes-for-brain-monitoring
WISE Enrols First Patient in Pivotal Clinical Study of Novel Neuro-Electrodes for Brain Monitoring
Published on 02/05/2019, 14:30 | 20973hits
sartorius-stedim-biotech-launches-new-ambr-15-cell-culture-microbioreactor-system
Sartorius Stedim Biotech Launches New ambr® 15 Cell Culture Microbioreactor System
Published on 02/05/2019, 10:00 | 19320hits
amal-therapeutics-enters-clinical-collaboration-with-boehringer-ingelheim-to-evaluate-atp128-in-combination-with-bi754091
AMAL Therapeutics Enters Clinical Collaboration with Boehringer Ingelheim to Evaluate ATP128 in Combination with BI754091
Published on 29/04/2019, 10:00 | 20015hits
implandata-successfully-gains-ce-mark-for-its-eyemate-system-for-an-orphan-eye-indication
Implandata Successfully Gains CE Mark for its EYEMATE System for an Orphan Eye Indication
Published on 25/04/2019, 09:00 | 19478hits
shuwen-presents-at-the-2nd-companion-diagnostic-i-o-biomarker-conference-in-shanghai
Shuwen Presents at The 2nd Companion Diagnostic & I-O Biomarker Conference in Shanghai
Published on 24/04/2019, 18:45 | 15769hits
new-data-show-blueprint-identifies-estrogen-receptor-positive-breast-cancer-patients-with-poor-response-to-anti-estrogen-therapy-who-may-benefit-from-neoadjuvant-chemotherapy
New Data Show BluePrint® Identifies Estrogen Receptor Positive Breast Cancer Patients with Poor Response to Anti-Estrogen Therapy Who May Benefit from Neoadjuvant Chemotherapy
Published on 24/04/2019, 09:00 | 19166hits
velabs-therapeutics-to-cooperate-with-chiome-bioscience-in-the-field-of-gpcr-specific-functional-antibody-screening
Velabs Therapeutics to Cooperate with Chiome Bioscience in the Field of GPCR-Specific Functional Antibody Screening
Published on 16/04/2019, 16:30 | 20328hits
vetter-s-skokie-facility-expansion-nears-completion
Vetter's Skokie Facility Expansion Nears Completion
Published on 28/03/2019, 12:00 | 21806hits
novel-first-in-class-flip-inhibitors-for-the-treatment-of-cancer
Novel First-In-Class FLIP Inhibitors for the Treatment of Cancer
Published on 28/03/2019, 10:00 | 24528hits
proteonic-biotechnology-licenses-protein-production-technology-to-bayer
ProteoNic Biotechnology Licenses Protein Production Technology to Bayer
Published on 28/03/2019, 09:30 | 22365hits
bcg-digital-ventures-and-sartorius-help-launch-the-world-s-first-voice-powered-digital-assistant-for-scientists
BCG Digital Ventures and Sartorius Help Launch the World’s First Voice-Powered Digital Assistant for Scientists
Published on 28/03/2019, 09:00 | 23922hits
tasly-pharmaceutical-group-taps-shuwen-biotech-for-companion-diagnostic-services
Tasly Pharmaceutical Group Taps Shuwen Biotech for Companion Diagnostic Services
Published on 27/03/2019, 14:45 | 19051hits
ambr-15-fermentation-and-ambr-250-high-throughput-systems-now-available-with-integrated-online-biomass-measurement-for-microbial-applications
ambr® 15 Fermentation and ambr® 250 High Throughput Systems Now Available with Integrated Online Biomass Measurement for Microbial Applications
Published on 26/03/2019, 09:00 | 18917hits
eur-3-million-in-series-a-for-the-growth-and-development-of-cytena-gmbh
EUR 3 Million in Series A for the Growth and Development of Cytena GmbH
Published on 25/03/2019, 09:00 | 24322hits
implandata-successfully-gains-ce-mark-for-next-generation-eyemate-system-and-poised-for-european-wide-market-launch
Implandata Successfully Gains CE Mark for Next-Generation EyeMate System and Poised for European-Wide Market Launch
Published on 22/03/2019, 09:00 | 19182hits
alzprotect-starts-collaboration-with-parexel-biotech-for-phase-2a-of-azp2006-for-the-treatment-of-progressive-supranuclear-palsy-psp
AlzProtect Starts Collaboration with PAREXEL Biotech for Phase 2a of AZP2006 for the Treatment of Progressive Supranuclear Palsy (PSP)
Published on 21/03/2019, 16:00 | 19454hits
customers-experience-leads-to-a-highly-successful-outcome-for-vetter-at-the-2019-cmo-leadership-awards
Customers’ Experience Leads to a Highly Successful Outcome for Vetter at the 2019 CMO Leadership Awards
Published on 21/03/2019, 10:00 | 19442hits
ab2-bio-announces-readiness-for-recruitment-in-pivotal-phase-3-trial-of-tadekinig-alfa-a-novel-human-recombinant-interleukin-18-binding-protein-in-children-with-genetic-diagnosis-of-nlrc4-mas-mutation-or-xiap-deficiency-with-amended-design-in-the-u-s
AB2 Bio Announces Readiness for Recruitment in Pivotal Phase 3 Trial of Tadekinig Alfa, a Novel Human Recombinant Interleukin-18 Binding Protein, in Children with Genetic Diagnosis of NLRC4-MAS Mutation or XIAP Deficiency, with Amended Design in the U.S.
Published on 21/03/2019, 09:00 | 22116hits
lead-pharma-announces-start-of-phase-i-clinical-trials-with-sar441169-candidate-treatment-for-psoriasis
Lead Pharma Announces Start of Phase I Clinical Trials with SAR441169 Candidate Treatment for Psoriasis
Published on 20/03/2019, 08:00 | 21712hits
domainex-and-spirochem-enter-a-fragment-drug-discovery-partnership
Domainex and SpiroChem Enter a Fragment Drug Discovery Partnership
Published on 19/03/2019, 21:00 | 21946hits
sotio-s-dcvac-ovca-significantly-improves-survival-in-patients-with-recurrent-ovarian-cancer
SOTIO’s DCVAC/OvCa Significantly Improves Survival in Patients with Recurrent Ovarian Cancer
Published on 18/03/2019, 10:00 | 19125hits
cellesce-announces-license-agreement-with-hubrecht-organoid-technology-hub-for-the-expansion-of-breast-cancer-organoids-at-scale
Cellesce Announces License Agreement with Hubrecht Organoid Technology (HUB) for the Expansion of Breast Cancer Organoids at Scale
Published on 13/03/2019, 10:00 | 19527hits
deuterium-depletion-is-a-disruptive-innovation-in-the-pharma-industry-hyd-pharma-develops-new-deuterium-depleted-drugs-for-the-treatment-of-neoplastic-and-metabolic-diseases
Deuterium Depletion is a Disruptive Innovation in the Pharma Industry - HYD Pharma Develops New Deuterium-Depleted Drugs for the Treatment of Neoplastic and Metabolic Diseases
Published on 13/03/2019, 09:00 | 21880hits
nbe-to-present-late-breaking-abstract-on-lead-adc-program-nbe-002-ror1-at-the-aacr-annual-meeting
NBE to Present Late-Breaking Abstract on Lead ADC Program NBE-002 (ROR1) at the AACR Annual Meeting
Published on 08/03/2019, 14:30 | 21016hits
third-sartorius-research-xchange-forum-2019-focuses-on-car-t-cell-therapy
Third Sartorius Research Xchange Forum 2019 Focuses on CAR-T Cell Therapy
Published on 07/03/2019, 17:00 | 21527hits
potential-new-treatment-for-heart-attack
Potential New Treatment for Heart Attack
Published on 07/03/2019, 11:00 | 22390hits
sotio-to-present-final-phase-ii-dcvac-ovca-data-at-the-2019-sgo-annual-meeting-on-women-s-cancer
SOTIO to Present Final Phase II DCVAC/OvCa Data at the 2019 SGO Annual Meeting on Women's Cancer
Published on 05/03/2019, 15:00 | 20256hits
adult-stem-cell-derived-kidney-on-a-chip-in-nature-biotechnology
Adult Stem Cell-Derived Kidney-on-a-Chip in Nature Biotechnology
Published on 05/03/2019, 14:00 | 23004hits
sartorius-stedim-biotech-and-novasep-to-develop-novel-systems-for-membrane-chromatography
Sartorius Stedim Biotech and Novasep to Develop Novel Systems for Membrane Chromatography
Published on 04/03/2019, 08:00 | 22783hits
novago-therapeutics-raises-chf-10-million-to-develop-regenerative-anti-nogo-therapy-for-stroke
NovaGo Therapeutics Raises CHF 10 Million to Develop Regenerative Anti-Nogo Therapy for Stroke
Published on 01/03/2019, 08:00 | 26667hits
neurimmune-appoints-john-dellapa-as-general-counsel
Neurimmune Appoints John Dellapa as General Counsel
Published on 28/02/2019, 15:15 | 22595hits
confo-therapeutics-forms-scientific-advisory-board-as-it-accelerates-development-of-proprietary-drug-discovery-engine
Confo Therapeutics Forms Scientific Advisory Board as It Accelerates Development of Proprietary Drug Discovery Engine
Published on 27/02/2019, 09:00 | 22894hits
cac-and-rfxcel-announce-a-partnership-agreement-for-pharmaceutical-traceability
CAC and rfxcel Announce a Partnership Agreement for Pharmaceutical Traceability
Published on 20/02/2019, 10:00 | 20447hits
sapreme-technologies-in-a-6-8-m-eu-alliance-to-develop-an-oligonucleotide-delivery-platform-based-on-its-proprietary-endosomal-escape-enhancers
Sapreme Technologies in a 6.8 M€ EU Alliance to Develop an Oligonucleotide Delivery Platform Based on Its Proprietary Endosomal Escape Enhancers
Published on 20/02/2019, 09:00 | 19183hits
calypso-biotech-bv-secures-20-million-eur-in-series-a-financing-and-strengthens-team-to-develop-anti-il-15-therapeutic-antibody-for-autoimmune-diseases
Calypso Biotech BV Secures 20 Million EUR in Series A Financing and Strengthens Team to Develop Anti-IL-15 Therapeutic Antibody for Autoimmune Diseases
Published on 20/02/2019, 08:00 | 24060hits
alzprotect-on-track-for-a-phase-2-entry-in-2019-for-its-drug-candidate-azp2006
AlzProtect, on Track for a Phase 2 Entry in 2019, for its Drug Candidate AZP2006
Published on 19/02/2019, 09:00 | 23684hits
rsp-systems-to-exhibit-its-cutting-edge-non-invasive-glucose-monitor-glucobeam-at-attd-2019
RSP Systems to Exhibit Its Cutting-Edge Non-Invasive Glucose Monitor, GlucoBeam at ATTD 2019
Published on 13/02/2019, 14:00 | 20162hits
haselmeier-acquires-drug-manufacturing-license-and-now-offers-assembly-labelling-and-packaging-services-to-pharmaceutical-and-biotechnology-companies
Haselmeier Acquires Drug Manufacturing License and Now Offers Assembly, Labelling and Packaging Services to Pharmaceutical and Biotechnology Companies
Published on 08/02/2019, 14:15 | 23407hits
andrew-alliance-and-sartorius-collaborate-to-provide-software-connected-pipettes-for-life-science-research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Published on 07/02/2019, 09:30 | 23612hits
cellmid-significant-new-findings-published-on-midkine
Cellmid: Significant New Findings Published on Midkine
Published on 05/02/2019, 13:00 | 32466hits
audion-therapeutics-and-regain-consortium-announce-positive-phase-i-results-in-patients-with-sensorineural-hearing-loss
Audion Therapeutics and REGAIN Consortium Announce Positive Phase I Results in Patients with Sensorineural Hearing Loss
Published on 05/02/2019, 12:00 | 24108hits
sotio-appoints-dr-harald-fricke-as-chief-medical-officer
SOTIO Appoints Dr. Harald Fricke as Chief Medical Officer
Published on 05/02/2019, 09:00 | 26734hits
proteonic-biotechnology-licenses-protein-production-technology-to-eli-lilly-and-company
ProteoNic Biotechnology Licenses Protein Production Technology to Eli Lilly and Company
Published on 31/01/2019, 17:30 | 23253hits
sartorius-joins-the-community-of-the-national-institute-for-innovation-in-manufacturing-biopharmaceuticals-niimbl
Sartorius Joins the Community of the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)
Published on 31/01/2019, 10:00 | 23734hits
hitachi-chemical-co-ltd-to-acquire-apceth-biopharma-gmbh
Hitachi Chemical Co. Ltd. to Acquire apceth Biopharma GmbH
Published on 24/01/2019, 10:00 | 24046hits
new-combined-diagnostic-and-antimicrobial-susceptibility-test-enables-resistance-guided-therapy-for-gonorrhoea
New Combined Diagnostic and Antimicrobial Susceptibility Test Enables Resistance-Guided Therapy for Gonorrhoea
Published on 23/01/2019, 14:40 | 23646hits
sartorius-stedim-biotech-offers-services-for-characterization-of-new-biological-entities-nbe
Sartorius Stedim Biotech Offers Services for Characterization of New Biological Entities (NBE)
Published on 22/01/2019, 13:30 | 23918hits
crispr-therapeutics-and-probiogen-sign-collaboration-and-license-agreement-to-develop-novel-in-vivo-delivery-technologies
CRISPR Therapeutics and ProBioGen Sign Collaboration and License Agreement to Develop Novel In Vivo Delivery Technologies
Published on 22/01/2019, 13:30 | 23972hits
orchard-announces-publication-by-san-raffaele-telethon-institute-for-gene-therapy-of-otl-300-clinical-data-for-the-treatment-of-transfusion-dependent-beta-thalassemia-in-nature-medicine
Orchard Announces Publication by San Raffaele-Telethon Institute for Gene Therapy of OTL-300 Clinical Data for the Treatment of Transfusion-Dependent Beta-Thalassemia in Nature Medicine
Published on 21/01/2019, 13:30 | 24529hits
sartorius-stedim-biotech-introduces-biostat-rm-tx-with-flexsafe-rm-tx-for-producing-consistent-quality-cellular-products
Sartorius Stedim Biotech Introduces BIOSTAT® RM TX with Flexsafe® RM TX for Producing Consistent Quality Cellular Products
Published on 21/01/2019, 12:00 | 19684hits
minervax-announces-award-of-4-4-million-euro-in-investment-from-novo-holdings-repair-impact-fund-and-sunstone-capital-for-further-clinical-development-of-the-company-s-vaccine-against-group-b-streptococcus-gbs
MinervaX Announces Award of 4.4 Million Euro in Investment from Novo Holdings REPAIR Impact Fund and Sunstone Capital for Further Clinical Development of the Company’s Vaccine Against Group B Streptococcus (GBS)
Published on 10/01/2019, 14:00 | 21761hits
toxys-appoints-four-new-board-members-to-accelerate-business-growth
Toxys Appoints Four New Board Members to Accelerate Business Growth
Published on 10/01/2019, 09:00 | 24747hits
clinigen-extends-exclusive-european-clinical-trial-sourcing-and-supply-agreement-with-accord-healthcare
Clinigen Extends Exclusive European Clinical Trial Sourcing and Supply Agreement with Accord Healthcare
Published on 07/01/2019, 14:00 | 24861hits
orchard-therapeutics-highlights-recent-accomplishments-and-2019-strategic-priorities-as-a-global-leader-in-gene-therapy
Orchard Therapeutics Highlights Recent Accomplishments and 2019 Strategic Priorities as a Global Leader in Gene Therapy
Published on 07/01/2019, 09:00 | 24387hits
velabs-therapeutics-to-cooperate-with-biomed-x-in-the-field-of-immunology
Velabs Therapeutics to Cooperate with BioMed X in the Field of Immunology
Published on 14/12/2018, 13:30 | 25243hits
orchard-therapeutics-and-sirion-biotech-announce-licensing-agreement-to-enhance-gene-therapy-manufacturing-efficiency
Orchard Therapeutics and SIRION Biotech Announce Licensing Agreement to Enhance Gene Therapy Manufacturing Efficiency
Published on 14/12/2018, 09:00 | 26873hits
prestige-biopharma-partners-with-cipla-ltd-to-market-key-cancer-biosimilar
Prestige BioPharma Partners with Cipla Ltd to Market Key Cancer Biosimilar
Published on 13/12/2018, 13:30 | 25936hits
orchard-therapeutics-announces-the-build-out-of-new-gene-therapy-manufacturing-facility-in-california
Orchard Therapeutics Announces the Build-out of New Gene Therapy Manufacturing Facility in California
Published on 11/12/2018, 13:00 | 25750hits
batavia-biosciences-partners-with-iavi-to-advance-development-of-vaccine-against-lassa-fever
Batavia Biosciences Partners with IAVI to Advance Development of Vaccine Against Lassa Fever
Published on 07/12/2018, 13:30 | 26239hits
orchard-therapeutics-appoints-industry-veteran-alicia-secor-to-its-board-of-directors
Orchard Therapeutics Appoints Industry Veteran Alicia Secor to its Board of Directors
Published on 07/12/2018, 09:00 | 25765hits
shuwen-biotech-wins-at-the-7th-annual-china-innovation-and-entrepreneurship-competition
Shuwen Biotech Wins at the 7th Annual China Innovation and Entrepreneurship Competition
Published on 05/12/2018, 13:30 | 22852hits
donald-b-kohn-md-orchard-therapeutics-scientific-advisory-board-member-presents-clinical-proof-of-concept-data-for-otl-102-gene-therapy-for-the-treatment-of-patients-with-x-cgd-at-the-presidential-symposium-at-the-2018-ash-annual-meeting
Donald B. Kohn, MD, Orchard Therapeutics Scientific Advisory Board Member, Presents Clinical Proof-of-Concept Data for OTL-102 Gene Therapy for the Treatment of Patients with X-CGD at the Presidential Symposium at the 2018 ASH Annual Meeting
Published on 04/12/2018, 09:30 | 25832hits
dr-irina-buhimschi-joins-shuwen-biotech-as-a-scientific-advisor
Dr. Irina Buhimschi Joins Shuwen Biotech as a Scientific Advisor
Published on 03/12/2018, 11:00 | 28411hits
first-patient-successfully-implanted-with-implandata-s-novel-eye-pressure-sensor-for-continual-glaucoma-monitoring
First Patient Successfully Implanted with Implandata’s Novel Eye Pressure Sensor for Continual Glaucoma Monitoring
Published on 28/11/2018, 12:00 | 26188hits
biontech-mammatyper-validated-as-predictor-for-response-after-neoadjuvant-chemotherapy-nact-in-patients-with-early-breast-cancer-bc
BioNTech: MammaTyper® Validated as Predictor for Response After Neoadjuvant Chemotherapy (NACT) in Patients with Early Breast Cancer (BC)
Published on 26/11/2018, 10:00 | 22839hits
immune-regulation-announces-positive-results-from-phase-1-clinical-trial-of-pin201104
Immune Regulation Announces Positive Results from Phase 1 Clinical Trial of PIN201104
Published on 21/11/2018, 18:00 | 26547hits
selvita-announces-presentations-on-cdk8-inhibitor-sel120-at-the-60th-american-society-of-hematology-annual-meeting
Selvita Announces Presentations on CDK8 Inhibitor SEL120 at the 60th American Society of Hematology Annual Meeting
Published on 19/11/2018, 09:00 | 28562hits
restoring-sight-clinical-progress-towards-australia-s-bionic-eye
Restoring Sight: Clinical Progress Towards Australia’s Bionic Eye
Published on 16/11/2018, 15:00 | 26936hits
elpis-biomed-wins-cambridge-start-up-of-the-year
Elpis Biomed Wins Cambridge Start-Up of the Year
Published on 15/11/2018, 09:00 | 25919hits
dr-anthony-tolcher-joins-the-scientific-advisory-board-of-nbe-therapeutics
Dr. Anthony Tolcher Joins the Scientific Advisory Board of NBE-Therapeutics
Published on 14/11/2018, 12:00 | 26596hits
top-oncologist-dr-samuel-fourie-joins-advisory-board-of-azargen-biotechnologies
Top Oncologist, Dr Samuel Fourie, Joins Advisory Board of AzarGen Biotechnologies
Published on 12/11/2018, 10:00 | 26791hits
amal-therapeutics-finalises-29-million-chf-33-2-million-series-b-round
AMAL Therapeutics Finalises €29 Million (CHF 33.2 Million) Series B Round
Published on 12/11/2018, 09:00 | 23849hits
retipharma-secures-funding-to-develop-treatments-of-degenerative-eye-disorders
RetiPharma Secures Funding to Develop Treatments of Degenerative Eye Disorders
Published on 09/11/2018, 18:00 | 22939hits
icosabutate-latest-data-shows-direct-and-potent-anti-fibrotic-effect-in-both-differentiated-rodent-nash-models-and-human-stellate-cells
Icosabutate Latest Data Shows Direct and Potent Anti-Fibrotic Effect in Both Differentiated Rodent NASH Models and Human Stellate Cells
Published on 09/11/2018, 14:45 | 25813hits
t3-pharmaceuticals-wins-prestigious-falling-walls-venture-award-for-its-bacterial-cancer-therapy
T3 Pharmaceuticals Wins Prestigious Falling Walls Venture Award for Its Bacterial Cancer Therapy
Published on 08/11/2018, 16:40 | 26604hits
selvita-to-present-new-data-from-sel120-program-at-eortc-nci-aacr-symposium-on-molecular-targets-and-cancer-therapeutics
Selvita to Present New Data from SEL120 Program at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Published on 08/11/2018, 15:40 | 31400hits
orchard-therapeutics-strengthens-global-commercial-leadership-team-with-appointments-of-heads-of-us-and-emea-region-commercial-operations
Orchard Therapeutics Strengthens Global Commercial Leadership Team with Appointments of Heads of US and EMEA Region Commercial Operations
Published on 06/11/2018, 10:00 | 25965hits
probiogen-announces-successful-bispecific-glymaxx-development-project-for-zymeworks
ProBioGen Announces Successful Bispecific GlymaxX® Development Project for Zymeworks
Published on 05/11/2018, 13:00 | 24049hits
orchard-therapeutics-announces-closing-of-225-million-initial-public-offering-including-the-partial-exercise-of-underwriters-option
Orchard Therapeutics Announces Closing of $225 Million Initial Public Offering, Including the Partial Exercise of Underwriters' Option
Published on 31/10/2018, 14:30 | 25823hits
selvita-to-present-new-data-from-its-oncology-programs-at-the-upcoming-sitc-2018
Selvita to Present New Data from its Oncology Programs at the Upcoming SITC 2018
Published on 31/10/2018, 08:45 | 26202hits
orchard-therapeutics-announces-pricing-of-initial-public-offering
Orchard Therapeutics Announces Pricing of Initial Public Offering
Published on 25/10/2018, 16:00 | 26622hits
elpis-biomed-human-cell-models-could-potentially-replace-animal-experiments-in-drug-discovery
Elpis Biomed Human Cell Models Could Potentially Replace Animal Experiments in Drug Discovery
Published on 25/10/2018, 09:00 | 26080hits
cristal-therapeutics-initiates-phase-2-clinical-trial-of-innovative-cripec-nanomedicine-drug-candidate-in-ovarian-cancer
Cristal Therapeutics Initiates Phase 2 Clinical Trial of Innovative CriPec® Nanomedicine Drug Candidate in Ovarian Cancer
Published on 24/10/2018, 15:45 | 23342hits
vetter-further-expands-secondary-packaging
Vetter Further Expands Secondary Packaging
Published on 22/10/2018, 13:00 | 26886hits
change-of-company-name-vtu-technology-is-now-validogen
Change of Company Name: VTU Technology is now VALIDOGEN
Published on 22/10/2018, 09:15 | 25881hits
polyganics-initiates-first-in-human-trial-of-liqoseal-its-innovative-approach-for-dural-closure
Polyganics Initiates First-in-Human Trial of LIQOSEAL®, its Innovative Approach for Dural Closure
Published on 19/10/2018, 13:30 | 24542hits
apceth-biopharma-presents-positive-data-demonstrating-efficacy-of-apceth-201-in-preclinial-models-of-acute-gvhd
apceth Biopharma Presents Positive Data Demonstrating Efficacy of apceth-201 in Preclinial Models of Acute GvHD
Published on 11/10/2018, 09:30 | 27113hits
ime-medical-electrospinning-enters-into-development-cooperation-with-leading-chinese-medical-devices-company-amor-medical
IME Medical Electrospinning Enters into Development Cooperation with Leading Chinese Medical Devices Company Amor Medical
Published on 11/10/2018, 09:00 | 26731hits
not-just-for-pharma-anymore-rfxcel-extends-track-trace-solutions-to-food-beverage
Not Just for Pharma Anymore: rfxcel Extends Track & Trace Solutions to Food & Beverage
Published on 08/10/2018, 14:00 | 21438hits
tfs-collaboration-with-lobsor-pharmaceuticals-ab-on-the-development-of-lecigon-has-resulted-in-marketing-authorization-of-lecigon-in-sweden
TFS Collaboration with Lobsor Pharmaceuticals AB, on the Development of Lecigon®, Has Resulted in Marketing Authorization of Lecigon® in Sweden
Published on 05/10/2018, 12:45 | 24389hits
apceth-to-manufacture-first-potential-one-time-gene-therapy-for-transfusion-dependent-beta-thalassemia
apceth to Manufacture First Potential One-Time Gene Therapy for Transfusion-Dependent Beta-Thalassemia
Published on 04/10/2018, 14:01 | 24115hits
orchard-therapeutics-receives-ema-prime-designation-for-otl-300-an-investigational-lentiviral-gene-therapy-for-the-treatment-of-transfusion-dependent-beta-thalassemia
Orchard Therapeutics Receives EMA PRIME Designation for OTL-300, an Investigational Lentiviral Gene Therapy for the Treatment of Transfusion-Dependent Beta-Thalassemia
Published on 04/10/2018, 09:30 | 27841hits
metp-pharma-introduces-nascum-plus-against-the-onset-of-air-pollution-induced-inflammation
MetP® Pharma Introduces Nascum®-Plus Against the Onset of Air Pollution-induced Inflammation
Published on 01/10/2018, 14:30 | 24154hits
new-flash-purification-system-and-columns-from-biotage
New Flash Purification System and Columns from Biotage
Published on 26/09/2018, 15:15 | 26859hits
vetter-grants-award-for-novel-idea-at-the-open-innovation-challenge-injection-2-0
Vetter Grants Award for Novel Idea at the Open Innovation Challenge – Injection 2.0
Published on 26/09/2018, 11:45 | 24790hits
transplantation-medicine-c-cit-sensors-to-provide-biosensors-for-ex-vivo-liver-perfusion-machine-of-wyss-zurich-project-liver4life
Transplantation Medicine: C-CIT Sensors to Provide Biosensors for Ex Vivo Liver Perfusion Machine of Wyss Zurich Project Liver4Life
Published on 20/09/2018, 08:00 | 24764hits
medtech-company-ime-medical-electrospinning-establishes-new-high-tech-production-facility-to-set-the-world-wide-standard-for-ground-breaking-regenerative-medicine-solutions
Medtech Company IME Medical Electrospinning Establishes New High-Tech Production Facility to Set The World Wide Standard for Ground Breaking Regenerative Medicine Solutions
Published on 18/09/2018, 14:30 | 27334hits
dominick-arena-joins-implandata-ophthalmic-products-gmbh-board-of-directors-as-chairman
Dominick Arena Joins Implandata Ophthalmic Products GmbH Board of Directors as Chairman
Published on 18/09/2018, 08:00 | 26975hits
neurimmune-achieves-milestone-in-collaboration-with-ono-pharmaceutical
Neurimmune Achieves Milestone in Collaboration with Ono Pharmaceutical
Published on 17/09/2018, 09:30 | 27095hits
shuwen-biotech-s-pd-l1-detection-kit-validated-in-clinical-trials-of-leading-drugs
Shuwen Biotech‘s PD-L1 Detection Kit Validated in Clinical Trials of Leading Drugs
Published on 10/09/2018, 09:00 | 24827hits
rsp-systems-adds-eur-3-85-million-in-a-second-closing-of-its-series-b-funding-round-increasing-the-round-total-to-eur-10-35-million
RSP Systems Adds EUR 3,85 Million in a Second Closing of its Series B Funding Round, Increasing the Round Total to EUR 10,35 Million
Published on 09/09/2018, 09:00 | 27376hits
menarini-will-bring-lunaphore-s-ultra-rapid-tissue-staining-solution-labsat-frozen-to-market
Menarini Will Bring Lunaphore’s Ultra-Rapid Tissue Staining Solution LabSat™ Frozen to Market
Published on 05/09/2018, 13:45 | 24073hits
thrombolytic-science-initiates-phase-2-clinical-trial-of-its-novel-treatment-regimen-for-ischemic-stroke
Thrombolytic Science Initiates Phase 2 Clinical Trial of its Novel Treatment Regimen for Ischemic Stroke
Published on 04/09/2018, 17:30 | 31110hits
sartorius-stedim-biotech-and-repligen-corporation-partner-to-introduce-next-generation-perfusion-enabled-bioreactors
Sartorius Stedim Biotech and Repligen Corporation Partner to Introduce Next-Generation Perfusion-Enabled Bioreactors
Published on 30/08/2018, 12:00 | 27811hits
sotio-and-ppf-complete-acquisition-of-cytune-pharma
SOTIO and PPF Complete Acquisition of Cytune Pharma
Published on 29/08/2018, 12:15 | 27591hits
orchard-therapeutics-expands-leadership-team-with-appointments-of-head-of-corporate-communications-and-head-of-human-resources
Orchard Therapeutics Expands Leadership Team with Appointments of Head of Corporate Communications and Head of Human Resources
Published on 20/08/2018, 09:00 | 25424hits
c-cit-sensors-single-use-cell-culture-in-situ-technologies-for-the-simultaneous-automated-and-continuous-monitoring-of-glucose-and-lactate-in-cell-cultures
C-CIT Sensors: Single-use Cell Culture In-situ Technologies for the Simultaneous Automated and Continuous Monitoring of Glucose and Lactate in Cell Cultures
Published on 16/08/2018, 09:00 | 27625hits
rfxcel-enhances-pharmaceutical-track-and-trace-solution-for-russia
rfxcel Enhances Pharmaceutical Track and Trace Solution for Russia
Published on 13/08/2018, 10:00 | 29587hits
orchard-therapeutics-announces-150-million-series-c-financing-to-advance-gene-therapy-pipeline
Orchard Therapeutics Announces $150 Million Series C Financing to Advance Gene Therapy Pipeline
Published on 07/08/2018, 09:30 | 28300hits
rsp-systems-is-awarded-the-iso-13485-2016-certification-from-lrqa-an-important-milestone-towards-ce-marking-and-product-launch
RSP Systems is Awarded the ISO 13485:2016 Certification from LRQA, an Important Milestone Towards CE Marking and Product Launch
Published on 02/08/2018, 10:00 | 27607hits
orchard-therapeutics-appoints-jon-ellis-to-board-of-directors
Orchard Therapeutics Appoints Jon Ellis to Board of Directors
Published on 02/08/2018, 09:00 | 27980hits
turkish-pharmaceutical-industry-leader-abdi-ibrahim-selects-rfxcel-for-fmd-compliance
Turkish Pharmaceutical Industry Leader, Abdi Ibrahim, Selects rfxcel for FMD Compliance
Published on 23/07/2018, 09:00 | 29125hits
azafaros-b-v-secures-seed-funding-to-develop-new-treatments-in-rare-metabolic-disorders
Azafaros B.V. Secures Seed Funding to Develop New Treatments in Rare Metabolic Disorders
Published on 19/07/2018, 14:45 | 37897hits
kite-and-gadeta-announce-strategic-collaboration-to-advance-gamma-delta-t-cell-receptor-technology-for-solid-tumors
Kite and Gadeta Announce Strategic Collaboration to Advance Gamma Delta T Cell Receptor Technology for Solid Tumors
Published on 19/07/2018, 09:30 | 27885hits
shuwen-biotech-s-clinical-lab-successfully-passes-biyearly-college-of-american-pathologists-audit
Shuwen Biotech's Clinical Lab Successfully Passes Biyearly College of American Pathologists Audit
Published on 17/07/2018, 11:30 | 31110hits
polares-medical-closes-a-25m-financing-to-enter-clinical-validation
Polares Medical Closes a $25M Financing to Enter Clinical Validation
Published on 17/07/2018, 09:00 | 29341hits
leon-nanodrugs-supports-takeda-in-a-feasibility-assessment-of-leon-s-proprietary-microjet-reactor-mjr-nano-technology
leon-nanodrugs Supports Takeda in a Feasibility Assessment of leon’s Proprietary MicroJet Reactor (MJR®) Nano-Technology
Published on 12/07/2018, 15:00 | 29580hits
antabio-completes-12-5m-series-a
ANTABIO Completes € 12.5M Series A
Published on 12/07/2018, 08:00 | 27684hits
immatics-enters-into-a-strategic-partnership-with-genmab-to-develop-next-generation-bispecific-cancer-immunotherapies
Immatics Enters into a Strategic Partnership with Genmab to Develop Next Generation Bispecific Cancer Immunotherapies
Published on 10/07/2018, 10:00 | 29595hits
probiogen-and-pionyr-immunotherapeutics-initiate-a-second-immuno-oncology-contract-development-and-manufacturing-project
ProBioGen and Pionyr Immunotherapeutics Initiate a Second Immuno-oncology Contract Development and Manufacturing Project
Published on 09/07/2018, 10:00 | 30083hits
orchard-therapeutics-appoints-joanne-beck-ph-d-to-board-of-directors
Orchard Therapeutics Appoints Joanne Beck, Ph.D. to Board of Directors

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
Ok